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ABSTRACT 
Saccharomyces cerevisiae is a pleimorphic ascomycete, capable of growing in 
the yeast form or the pseudohyphal form. The pseudohyphal form is 
characterized by elongated cells that possess a unipolar budding pattern and grow 
in chains away from the center of the colony. This change in morphology is 
induced by nitrogen starvation in the presence of carbon. A collection of 14 elm 
(elongated morphology) mutants previously have been isolated that grow as 
pseudohyphae constitutively. Of these mutants, the product of the ELMl gene 
was identified and coded for a novel protein kinase. From genetic analyses, ELMl 
seemingly fimctioned downstream of STE7 and STEll, two genes that are 
essential for pseudohyphal growth. In this study, biochemical characterization of 
the ELMl gene product, Elmlp, revealed that Elmlp was a serine/threonine 
protein kinase. Elmlp autophosphorylated on serine and threonine residues and 
phosphorylated general phosphoacceptors histone HI, myelin basic protein, and 
casein. In addition, Elmlp catalytic activity was essential for growth in the yeast 
form. Elmlp was only detectable in yeast when tagged at the amino terminus. 
The protein was present in extremely low concentations and seemed to be tightly 
regulated, perhaps in a cell cycle dependent maimer. 
Results from morphological analyses showed that, when tagged versions of 
Elmlp were overexpressed, cell cycle progression was affected. Specifically, cells 
were blocked in G1 but budding continued. Nuclear division was impaired; nuclei 
did not divide but instead lodged between the mother and the bud. As a result, 
cytokinesis was defective. Results from genetic analyses of Elmlp 
overexpression in the other thirteen elm mutants suggested that ELMl is 
epistatic to the other elm mutants. 
viii 
To identify substrates and effectors of Elmlp, the protein-protein 
interaction trap was employed with Elmlp as the bait. Proteins that interacted 
with Elmlp in vivo were coded by cDNAs for elongation factor-la, ribosomal 
protein (rp) 2L, phospofructokinase, and two phosphoribosyltransferase homologs. 
Elmlp also bound to rp 2L in vitro and phosphorylated rp 2L in vitro. Results 
from this study indicate that Elmlp may regulate pseudohyphal growth through 
translational modification or nitrogen salvage pathways. 
1 
Chapter 1. INTRODUCTION 
General properties of protein kinases 
Protein kinases are a general class of enzymes that catalyze the transfer of 
a phosphate group from the donor onto an acceptor amino acid in the protein 
substrate. Generally, the donor is the y-phosphate of ATP or GTP. Of all the 
proteins in the cell, approximately 60% of the proteins can be phosphorylated. 
Thus, phosphorylation is a basic step in protein regulation. 
Protein kinases are categorized by the residue that is phosphorylated 
becaxise many protein kinases recognize multiple substrates (41), Five general 
classes exist: 
1. Phosphotransferases with a protein alcohol group as the acceptor are 
called protein-serine/threonine kinases. 
2. Protein-tyrosine kinases catalyze phosphotransfer to the phenolic group 
on tyrosine. 
3. Phosphotransferases with a protein histidine, arginine, or lysine group as 
acceptor are called protein-histidine kinases. 
4. Phosphotransferases with a protein cysteine group as the acceptor are 
called protein-cysteine kinases. 
5. Phosphotransferases with a protein acyl group as acceptor are called 
protein-aspartyl or glutamyl kinases. 
The most common protein kinases are in the serine/threonine protein 
kinase and tyrosine protein kinase groups. Protein kinases in the other three 
groups have not been characterized as well as serine/threonine protein kinases; 
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some of the histidine, cysteine, and aspartate/glutamate protein kinases have 
been identified in prokaryotes (41). 
Hxmdreds of protein kinases have been identified. The primary structure of 
protein kinases all contain a readily identifiable catalytic core of 250-300 residues 
by homology (35). However, the method in which they are regulated varies 
greatly. Some kinases are simply regulated by phosphorylation at positive and 
negative regulatory sites, while more complex kinases are controlled by positive 
and negative regulatory domains coded in the same polypeptide or in separate 
regulatory subunits. Regulatory domains may be controlled by phosphorylation, 
C5d;oplasmic Ugands, or extracellular ligands such as growth factors. 
By ahgnment comparisons between protein kinase sequences, consensus 
regions have been identified (36). Eleven major subdomains are evident, 
separated by regions of lower conservation including large gaps and inserts. In the 
alignment of 65 protein kinases, nine positions contain the identical amino acid 
residue (36); these invariant residues correspond to the catal3rtic subunit of cyclic 
AMP-dependent protein kinase A (cAPK-a); Gly52, Lys'^2^ Glu^l, Aspl66^ 
Asn^"^!, Aspl®^, GlylS6^ Glu^OS^ and Arg280_ An additional five positions 
contain the identical amino acid in all but one of the sequences: Gly^O, Val^^T^ 
Phel85^ Asp220^ and Gly225. Many of these highly conserved residues directly 
participate in ATP binding and phosphotransfer. In addition, residue Lys'^2 ig 
essential for cataljrtic activity; even conservative changes to Arg residt in loss of 
catalytic activity in cAPK-a and other protein kinases. The central core of the 
catalytic domain, the region with the greatest fi:equency of highly conserved 
residues, consists of subdomains VI through DL Subdomain VII contains the Asp-
Phe-Gly (DFG) box that is involved in ATP binding and subdomain VIII contains 
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the Ala-Phe-Glu (APE) box that is a key protein kinase catalytic domain indicator 
(36). The specificity of the protein kinase for serine/threonine or tyrosine residues 
is revealed by conserved residues in subdomains VI and VIII. The consensus Asp-
Leu-Lys-Phe-Glu-Asn in subdomain VI is a strong indicator of serine/threonine 
specificity, whereas the protein-tyrosine kinase consensus is either Asp-Leu-Arg-
Ala-Ala-Asn or Asp-Leu-Ala-Ala-Arg-Asn. In subdomain VIII, on the amino 
terminal side of the APE box, lies the region that is highly conserved among 
protein-tyrosine kinases and less conserved among the serine/threonine protein 
kinases. The protein-tyrosine kinase consensus through this region is Pro-IleA^al-
Lys/Arg-Trp-Thr/Met-Ala-Phe-Glu while the protein-serine/threonine kinase 
consensus is Gly-Thr/Ser-X-X-Tyr/Phe-Ala-Phe-Glu. 
A phylogenetic tree has been constructed fi:om the sequences of various 
protein kinases (36). Five major branch clusters are present: protein-tyrosine 
kinases, cyclic nucleotide- and calcixim-phospholipid-dependent protein kinases, 
calcium-calmodulin-dependent protein kinases, protein kinases closely related to 
SNFl, and protein kinases closely related to CDC28. In addition, a few of the 
protein kinases did not fall into any of these major clusters, (generally, a sequence 
found within one of these clusters shares in excess of 35% identical amino acids 
with each of the other sequences in the cluster, whereas the catal3rtic domain 
sequences that do not map within the same cluster have identities in the range of 
20 to 25% (36). 
Crystal structures of protein kinases 
The crystal structures of three protein kinases in various states of activity 
have been determined. The cataljiic subunit of cAPK has been crystallized in 
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complexes with various substrates and substrate analogs such as PKI, protein 
kinase inhibitor peptide (20,44, 45,106,107). These studies have revealed that 
cAPK contains two lobes: a smaller lobe, composed mainly of the amino-terminal 
region and the glycine anchoring region, and a larger carbojgr-terminal lobe 
containing the residues catalyzing phosphotransfer. ATP binds in the deep cleft 
between these lobes, such that the adenine base is buried deep in a hydrophobic 
pocket and the phosphates are oriented outward toward the entrance of the cleft. 
The protein substrate interacts mainly with the residues on the surface of the 
large carboxy-terminal lobe along the outer edge of the cleft. In the temaiy 
complex, the side chain of serine or threonine on a substrate is positioned adjacent 
to the Y-phosphate of ATP for phosphotransfer. 
The protein substrates of cAPK generally contain a consensus recognition 
site resembling the sequence Arg-Arg-X-Ser/Thr-Y, where X is any small residue 
and Y is a large hydrophobic residue. In the structure of the cAPK:PKI complex, 
the arginines at the P-2 and P-3 sites (P indicates the phosphorylated residue) 
interact with specific acidic residues on the face of the large lobe, while the 
hydrophobic residue at P+1 is buried in the hydrophobic pocket in the cleft (45). 
Substrate binding affects conformation of the protein kinase with respect 
to the size of the cleft between the two lobes. When the substrate binds, the cleft 
becomes closed as opposed to an open conformation in which the cleft is vacant of 
substrate. Crystal structure analysis confirms that the closed state is seen in 
complexes with PKI (107). 
Two additional protein kinases that have been crystallized are CDK2 and 
ERK2. CDK2 is a 34 kD cyclin dependent kinase protein that consists of a protein 
kinase cataljiiic core. Activation of the catalytic core occurs by association with 
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cyclins (the regulatory subunit) followed by phosphorylation of the CDK2 subunit 
by a separate protein kinase CAK, CDK-activating kinase. CDK2 has been 
crystallized alone and in a binary complex with Mg-ATP (19). CDK2 seemingly is 
inactive without association with cyclins because the ATP binding site is blocked 
by an autoinhibitory subdomain. Cyclin binding and Thr^S® phosphorylation 
must remove constraints imposed by this autoinhibitory domain (19). The CDK2 
crystal structure also provides some clues about negative regulation of kinase 
activity by phosphorylation at Thrl^ and Tyr^^. These residues are both in the 
glycine-rich loop directly above the phosphates of ATP, and thus phosphorylation 
at these sites could alter ATP orientation, protein substrate binding, or the general 
conformation of the active site. ERK2 (extracellular-stimulated receptor kinase) 
was crystallized in the unphosphorylated state, both as an apoenzyme and as an 
ERK2:Mg-ATP complex (105). This structure, Uke that of CDK2, represents an 
inactive conformation. A comparison of ERK2 and cAPK reveals that the 
inactivity of ERK2 is probably due to several conformational changes in the 
vicinity of the active site. 
Mechanism of action 
After the substrate contacts the protein kinase in the active site, binding is 
rapidly followed by transfer of the y-phosphate from ATP to the hydroxyl group of 
a serine or threonine in the protein substrate. The reaction mechanism of cAPK 
involves a general base in the active site of the kinase, which partially 
deprotonates the hydroxyl of the serine in the protein substrate. Deprotonation 
promotes nucleophilic attack by the hydro^grl oxygen of the y-phosphate of ATP 
(104). An inversion of the phosphorus configuration occurs during the 
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phosphotransfer, requiring the y-phosphate to be positioned in-line with the 
hydro:^! group (39). Crystal structure of cAPK:PK[:Mg-ATP complex, in which 
cAPK has been crystallized with protein kinase inhibitor and Mg*ATP in the active 
site, supports the mechanism of action (106). The J3- and y-phosphates of ATP are 
aligned with the P-site of the peptide substrate, and a nearby carbo^l group 
(Aspl®®) is well positioned to serve as the catalytic base. In addition, the primary 
Mg2+ ion that bridges the B- and y-phosphates, as well as a nearby lysine residue 
(Lys^®®), probably neutralize the y-phosphate charge and thus facilitate 
nucleophiUc attack by the hydro^l oxygen. 
Regulation of protein kinases 
In the cell, most protein kinases are kept in an inactive state imtil an 
upstream signal is activated and derepresses activity. In the case of cAPK, the 
catalytic subunit is normally repressed by binding of the regulatory domain that 
contains a pseudosubstrate sequence that occupies the active site cleft and 
competitively inhibits protein phosphorylation (97), Many other protein kinases 
are regulated by a similar mechanism (89). 
Phosphorylation may also play a role in activity. In cAPK, phosphorylation 
at Thr^^T jg required both for effective regulatory-subunit binding and for 
maximal catalytic activity (94). In movise, cAPK phosphorylation is requisite for 
enhanced activity, but in yeast, phosphorylation has only a moderate effects on 
protein kinase activity (31, 94). Perhaps, this site is autophosphorylated soon 
after translation and, thus, contributes to stability (94). Thr is firmly 
anchored in a cationic pocket formed by other kinase residues and may stabilize 
the DFG-APE loop, which is important for catalysis and substrate binding (36). 
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Like Thrl^"^ in cAPK, phosphorylated residues important for activity in other 
protein kinases such as CDK2, ERK2, Src, and the insulin receptor lie between 
kinase subdomains VII (contains conserved DFG) and VIII (contains conserved 
APE) (67). 
Signalling cascades involving protein phosphorylation 
Phosphorylation is an important mechanism in signal transduction 
pathways and cell cycle control in Saccharomyces cerevisiae. To date, several 
different MAP (microtubule-associated protein or mitogen-activated protein) 
kinase cascades have been identified in the budding yeast Saccharomyces 
cerevisiae that control celMar processes involved in mating, sponalation, stress, 
cell wall biosynthesis, and pseudohyphal growth in diploids and invasive growth in 
haploids. In addition, phosphorylation is important for progression through the ceU 
cycle. 
MAP kinases and their upstream regulatory kinases comprise a functional 
unit that couples upstream input signals to a variety of outputs (10,38, 64). 
MAP kinase (MAPK, also called ERK) itself is the defining character in this 
module. MAP kinase or MEK (for MAPK/ERK kinase) is a regulatory kinase that 
is necessary for the activation of MAPK MEK is in turn regulated by another 
kinase group termed MEKK (for MEK kinase) including raf and mos. In 
metazoans, the raf-MEK-MAPK module is regulated by coupling to membrane 
receptors in a process involving ras and its regulator SOS (9). 
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The pheromone response pathway 
The pheromone response pathway is necessary for haploid strains of yeast, 
which are of mating type a or a, to mate with each other. Haploids of each mating 
type produce a unique polypeptide mating pheromone (a-factor in a cells and a-
factor in a cells) that binds to receptors displayed by cells of the opposite mating 
type {STE2 in a cells, STE3 in a cells) (70); diploid cells do not produce pheromone. 
Sjnithesis of the receptors is governed at the transcriptional level by cell type-
specific regulatory proteins. Docking of a mating pheromone on its receptor 
residts in cellular changes that are regulated in the same manner in a and a cells 
and that are required for mating including G1 arrest, transcriptional activation, 
and alterations in cell shape and polarity which facilitate cell and nuclear fusion 
(59, 93). 
After interaction between the mating factor and the receptor, a signal is 
transduced. Activation of the receptor causes dissociation of Ga coded by GPAl 
(69) from Gpy coded by STE4 and STE18 (103), respectively, which then 
activates the MAPK cascade in an as yet unknown manner involving STE20 and 
STE5. STEll (95), the MEKK family member, is activated and then 
phosphorylates and activates STE7 (MEK) (13, 73), which in turn activates 
MAPKs FUSS and KSSl (25, 30, 51). The activated MAPKs then activate 
transcription factor STE12 by phosphorylation (23). STE12, often in association 
with the general transcription factor MCM2, then activates transcription of 
nxamerous genes coding for components of the pheromone response pathway (22, 
93). 
The targets of the MAPK cascade are numerous. Either FUS3 or KSSl is 
sufficient for activation of STE12. A double fus3 kssl mutant is sterile, however, 
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indicating these are the only two MAPKs that can activate STE12 (21). FUSS 
and KSSl also have nonoverlapping functions, FUSS propagates the signal for 
pheromone induced G1 cell cycle arrest, whereas KSSl plays a role in recovery 
from pheromone-induced cell cycle arrest. Fus3p directly phosphoiylates Farlp in 
vitro and in vivo (23, 77, 99). Farlp is a cell cycle inhibitor because it binds to 
cyclin-dependent kinase complexes CDC28-CLN1 and CDC28-CLN2 and 
prevents their activity (77), thus causing G1 cell cycle arrest. In addition, 
transcription of FARl is induced 3- to 5-fold by mating pheromones. Other 
substrates of Fus3p include Ste7p (108) and SteSp (47), but the functional 
consequences of phosphorylation are not known. Ksslp may stimulate Cdc28p 
dependent passage of cells from Gl- to S-phase after the mating process is 
complete, by promoting the activity of CLN3 (17). 
The function of STE5 is becoming evident. The STE5 nucleotide sequence 
reveals an ORF of 917 amino acids (52,68) but provides no clues to its function. 
Epistasis tests place STE5 between STE4ISTE18 and STE12 (37, 53, 95). 
Results from two-hybrid analyses (27) and biochemical assays have identified 
interactions among STE5 and the components of the MAPK cascade (15, 63, 78). 
SteSp associates with all components of the MAPK cascade, Stellp, Ste7p, 
Fus3p, and Ksslp. In contrast, SteSp does not associate with Ste4, Ste20p, or 
Stel2p. In addition, Ste5p co-immunoprecipitated and co-sedimented on glycerol 
gradients with the MAPK module components (15). Each of these components 
associates with a different region of SteSp. Thus, SteSp seemingly functions as a 
scaffold so that these members of the mating MAPK cascade associate with one 
another (15, 63, 78) and restrict cross-talk with components of other MAPK 
cascades. 
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One of the major vinanswered questions is how the signal is transmitted 
from Gjjy to MEKK Stellp. STE20 functions between the Gfiy and STEll (53, 
79). STE20 has structural features of a protein kinase and has striking identity 
to the kinase p65PA^; 70% of the residues in a segment of 250 amino acids 
containing the catalytic domain are identical (62). Stellp may be a substrate for 
Ste20p. The mammalian homolog pBS^-^ is stimulated by GTP-bound forms of 
mammalian Cdc42 and Rac proteins (62); p65P^K is analogous to raf in that it is 
a protein kinase whose activity is controlled by a GTPase. These observations on 
control of a STE20 relative by GTPases may be relevant to yeast and 
mammalian signal transduction systems. The yeast Cdc42p is necessary for cell 
polarity (43) and is reported to bind Ste20p (62), Control of Ste20p activity by 
Cdc42p could link morphogenesis and the pheromone response pathways. Future 
investigations with STE20 should reveal its role in regulation of the MAPK 
cascade in pheromone response. 
HOG pathway 
A MAPK cascade activated under conditions of stress such as high 
osmolarity has been reported in yeast (12). An osmotic gradient across the 
plasma membrane allows cells to take up water. When the external osmolarity 
increases, yeast respond by increasing glycerol synthesis and decreasing glycerol 
permeability, thereby accumulating cytoplasmic glycerol up to molar 
concentrations. Mutants that did not grow well on high-osmolarity medium 
accumulated cellvdar glycerol. Two genes HOGi(hypersensitivity to osmolar 
growth) and PBS2 (also called HOG4) that code for members of the MAPK family 
and MEK family respectively were found to be essential for growth in high 
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osmolality conditions (11,12). HOGl is most similar to other MAP kinases 
FUSS, KSSl, and ERKl. Like MAP kinases, Hoglp contains Thrl74 'jy^lTS 
in kinase subdomain VTII, which are indicative of these dual-specificity MAPKs. 
PBS2 {HOG4) is most similar to other members of the MEK family, STE7, byrl, 
and MEK In response to increases in extracellular osmolarily, rapid PBS2-
dependent tyrosine phosphorylation of Hoglp occurred. A downstream target of 
this pathway may be a transcription factor analogous to STE12 that regulates 
transcription fi-om the high osmolarity regulatory element (1, 86). HOGl and 
PBS2 seemingly are required only in osmosensitivity as they are not required for 
the mating pheromone response and cell wall biosynthesis pathways. In addition, 
homologs in mammalian cells have been identified, suggesting that a MAP kinase 
cascade for stress response is conserved among different species. 
Although a MEKK for this pathway has not yet been identified, candidates 
for components that function early in the HOG pathway have been identified. 
These products may comprise a eukaryotic version of a two-component 
regulatory system hke those in bacteria. The yeast SLNl gene was identified in a 
mutagenesis screen for mutants that could not tolerate a defect in proteolysis and 
the ORF was homologous to bacterial two-component regulators (75). SLNl 
contains two putative transmembrane domains, suggesting that it is an integral 
membrane protein receptor. In addition, it contains regions that are similar to 
sensor histidine kinase and to the response regulator domains of bacterial two-
component systems (75). Mutations in HOGl, PBS2, and SSKl (for suppressor of 
sensor kinase) allowed growth of an slnl mutant (61). SSKl is homologous to 
bacterial response-regulatory domains (61). Ssklp fiinctions prior to Hoglp, 
because overexpression of Ssklp induced tyrosine phosphorylation of Hoglp. 
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Thus, the receptor component Slnlp may control the activity of Ssklp, the 
regulatory domain. Because inactivation of SSKl, PBS2, or HOGl reverses the 
lethality exhibited by an slnl mutant, it has been proposed that SLNl inhibits 
SSKl and that high osmolarity inhibits SLNl, thereby allowing SSiTi to stimulate 
PBS2 (MEK) and HOGl (MAPK) (61). 
A MAPK pathway regulates cell wall integrity 
Yeast contain one protein kinase C (PRC) that has been well characterized 
genetically and biochemically (4, 58, 76,102), PKC is coded by the PKCl gene and 
is a homolog of a, 13, and y isoforms of mammalian PKC (58). Unlike mammalian 
PKC, yeast PKC activity does not exhibit phospholipid dependence (102). pkcl 
mutants exhibit a cell lysis defect at any temperature that can be suppressed by 
medium of high osmolarity such as IM sorbitol (56, 76). Growth of pkcl mutants 
under these conditions indicates that the major role of PKC is to ensure the 
integrity of the cell wall. 
The components of the pathway in which PKC functions have been 
identified in screens to identify suppressors of the lysis defect (42, 54,55). The 
following genes have been identified: BCKl, a MEKK homolog (55); MKKl and 
MKK2, MEK homologs (42, 98); and MPK^SLTl, a MAPK homolog (54,98). 
MKKl and MKK2 are fimctionally redtmdant (42). Mutants lacking any of these 
components exhibit the same phenotype, lysis at a high temperature. PKC 
phosphorylates Bcklp in vitro, but the functional consequences of this 
phosphorylation are not known (57), Targets of MPKl have not yet been 
identified; the overproduction of the HMGl-like proteins NHP6A and NHP6B can 
suppress growth defects of mutants defective in the MEKK or MAPK components 
13 
of this pathway, suggesting that they may be substrates for MPKl (16). PKCl 
may control a bifurcated pathway, of which one arm is the MAPK cascade 
because pkcl mutants lyse at all temperatures and the downstream MAPK 
cascade mutants only lyse at high temperatures (55). 
A MAPK cascade may regulate spore formation 
Yeast sporulation is the process of meiosis followed by packaging of the 
haploid nuclei into spores. Sporulation is exhibited only by a/a diploid cells and 
requires nutritional starvation (66). Many events including gene expression and 
DNA replication, chromosome synapsis, the first and second meiotic segregation, 
and spore formation must be coordinated. Two yeast genes necessary for spore 
formation have been identified that code for MAPK cascade components. SMKl 
which codes for a putative MAPK was identified by PGR and is 40% identical to 
FUSS (48). SPSl codes for a STE20 homolog, with a homology of 44% in the 
catalj^ic domain (29). Phenotypes of smkl and spsl mutants are identical; they 
both proceed normally through the second meiotic division but then are defective 
in completing sporulation (29,48). The mutants produce defective spores with 
altered spore walls and express the late group of sporulation-specific genes at 
greatly reduced levels. In addition, SPSl and SMKl are regulated at the 
transcriptional level in a sporulation-specific manner. While investigations are 
preliminary, Spslp might regulate activity of the MEKK-MEK-MAPK module 
containing Smklp as its MAPK in a mechanism analogous to the pheromone 
response pathway. 
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A MAPK cascade regulates pseudohyphal growth 
Yeast cells are able to alter their growth state depending on their nutritional 
status. These states have been termed as pseudohyphal growth in diploid cells 
(33) and invasive growth in haploid cells (83). In haploid cells, individual cells 
growing on agar invade the agar and grow beneath the cell surface (83). The cells 
exhibit a change in budding pattern but the individual cells remain roimd in 
morphology. In contrast, diploid cells grow as pseudohyphae in which cells become 
elongated, exhibit imipolar budding and remain connected to form chains, and 
exhibit an altered cell cycle (33, 50). 
Invasive growth reqiiires STEll and STE7 of the MAPK module for 
pheromone response, in addition to the transcription factor STE12 (83). The 
requirements for FUSS and KSSl in invasive growth, are not clear and suggest 
that other MAPKs may be reqixired. Specifically, kssl FUSS mutants are 
defective in invasiveness and KSSl fusS mutants exhibit enhanced invasiveness. 
A kssl fusS mutant, however, exhibits invasiveness. Thus, these MAPKs only 
may modulate invasive growth of haploids (83). Haploid cells exhibit a stronger 
invasive growth response than diploid cells. This may be explained if al-a2, the 
repressor characteristic of a/a cells, turns off a pathway-specific component such 
as the MAPK or STE5 homolog. 
In contrast to haploid cells, diploid cells are dimorphic and able to grow as 
pseudohjHphae (33). The inducer of the transition fi:om the oval shaped, yeast-like 
form to the filamentous pseudohyphal form is nitrogen starvation in the presence 
of glucose. The pseudohyphal growth form is characterized by cells with an 
elongated morphology and that remain connected to each other, presumably by 
the cell wall. A unipolar budding pattern occijrs in which daughter cells bud and 
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rebud at the pole opposite the birth pole. The control in cell cycle has changed 
from the Gl/S transition, which occiars in cells in the yeast form, to the G2/M 
transition (49); the change in cell cycle control results in synchronous budding 
between the mother and daughter. The net result is an expanded, branched 
structure emanating away from the center of the colony. When grown on solid 
agar medium, pseudohyphal cells penetrate the agar and grow below the sxirface, 
Pseudohyphal cells may uniquely secrete glycohydrolases that aid in the foraging 
and exaggerated growth into the agar medium (33). 
Pseudohyphal growth also requires components of the MAPK module for 
pheromone response. STE20, STEll, STE7, and STE12 are required for 
pseudohyphal growth in diploid cells and mutants defective in FUS3, KSSl, or 
both exhibit normal pseudohyphal growth (60), Comparison of the pheromone 
response pathway and the pseudohyphal development pathway sheds insight into 
the roles of the individual players in these pathways. First, these pathways occur 
in different cell types; these components are differentially expressed. In diploid 
cells, the receptors, STE5, and FUSS are not expressed. Synthesis of STE12 is 
reduced 5-fold (26, 60). STE7 and STEll are expressed in all cell types. Another 
transcriptional factor PfiD2, a dominant regulator of pseudohj^hal growth, has 
been identified and may be activated like STE12 in the MAPK cascade (32). Thus, 
although several players of the MAPK cascade for pheromone response play a role 
in pseudohyphal growth, the mechanism is not yet clear. In addition, other 
proteins involved in this pathway most likely will be identified, including perhaps a 
STE5 homolog and other MAPKs. 
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Cell cycle 
Phosphorylation events play a major role in regulation of the S. cerevisiae 
cell cycle. A single 34 kD cyclin-dependent kinase (CDK) (p34C'^^^<5/cdc2, also 
known as cdkl) serves as a master controller of the cell cycle (84, 92), assembling 
sequentially into active holoenzyme complexes with Gl, S phase, or mitotic 
cyclins temporally to direct distinct transitions in cell cycle (72,80). Nine cyclin 
homologs have been identified, three Gl cyclins (.CLNs), and six G2 or B-type 
cyclins (CLBs). CLNl, CLN2, and CLN3/DAF1/WHI1 are cyclin homlogs that 
function in START and the Gl/S transition (18,34,59, 71, 82). These three genes 
likely perform some redundant functions because strains deleted for any one or 
two are viable whereas a triple CLNl, CLN2, CLN3 deletion is lethal (81). The six 
G2 cyclins make up three closely related homolog pairs; CLBl and CLB2, CLB3 
and CLB4, CLB5 and CLB6. CLBl and CLB2 are expressed in late S, G2, and M 
phase and function predominantly in the induction of mitotic events (28,81, 96). 
Either gene is not essential but a double deletion resxilts in G2 or M arrest. CLB3 
and CLB4 activate CDC28 earlier than CLBl and CLB2 and may be involved in 
DNA replication and early spindle assembly events (28,81). CLB5 and CLB6 
expression resembles that of CLNl and CLN2 in that they accumulate in late Gl 
and disappear after completion of S. Both CLB5 and CLB6 are involved in 
triggering DNA replication and mitosis (24,88). 
How does the cell progress through the cell cycle? In the presence of 
appropriate nutrients, Gl cells that reach a critical size initiate DNA replication, 
form buds, and duplicate their spindle pole bodies in preparation for subsequent 
division. Gl cyclins are required for these processes (82). Cln3-Cdc28 is present 
throughout Gl, and its kinase activity seems necessary for subsequent 
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transcriptional activation of the CLNl and CLN2 genes (100). In turn, the 
induced Clnl and Cln2 proteins associate with Cdc28, whose kinase activity 
further stimtilates CLNl and CLN2 transcription. CLNl and CLN2 gene 
expression is controlled by a heterodimeric transcription factor composed of Swi4p 
and Swi6p, and Cln-Cdc28-mediated phosphorylation events likely affect their 
activity (3). Positive feedback leads to an abrupt increase in Cln-Cdc28 kinase 
activity in late Gl, which is associated with commitment of cells to enter S phase 
(Start). Two B-type cyclins ClbSp and Clb6p, which are synthesized late in Gl 
and degraded as cells exit mitosis, are needed downstream for the actual onset of 
DNA replication (24, 87, 88). The kinase activities of Clb-Cdc28 complexes are 
regulated by an inhibitory protein Siclp (65, 74) that accumulates early in Gl and 
is degraded shortly before S phase (87). Phosphorylation of Siclp by Clnl-
Cln2/Cdc28 might trigger its ubiquitin-mediated degradation, thereby enabling the 
Cln-regulated kinases to control S phase entry indirectly. Once progression into S 
occurs, transcription of CLBl and CLB2 occurs and Clblp and Clb2p appear in 
G2 phase; Clbl-Clb2/Cdc28 activity appears in G2 phase for progression through 
M (2). Clblp and Clb2p expressed in Gl are not stable. Two additional G2 cyclins 
CLB3 and CLB4 also appear at the end of S and are required for formation of 
bipolar spindles and DNA replication (3). A clbl-4 mutant enters S with normal 
kinetics but fails to form bipolar spindles (3). Thus, the association of CDK 
Cdc28p with various cyclins regulates progression through the cell cycle. 
Mechanisms regulating pseudohyphal growth 
The study of pseudohyphal growth in S. cerevisiae is in its infancy, hence, 
specific mechanisms regulating this pathway are not known. Other dimorphic 
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fungi include Candida albicans and Ustilago maydis. In these fungi, switching 
from yeast-like to filamentous growth often correlates with a change from a 
nonpathogenic to a pathogenic state. For example, U. maydis in the unicellular 
form is not pathogenic, but as a highly elongated dikaryon, is pathogenic and 
parasitic to com tissue, causing com smut (5). A second well characterized 
example of cellular dimorphism occurs in C. albicans (85,90, 91). This himian 
pathogen exhibits a basic dimorphism between a budding yeast and a hyphal 
form. The growth s^ate is determined by environmental factors such as 
temperature, pH, nutrient availability, and exposure to serum factors . While 
analysis of the cjrtology of the yeast-hyphal transition has been productive, 
classical genetic analysis of this phenomenon has been limited because C. 
albicans does not have a sexual cycle (14, 40). Lack of a sexual cycle has made 
the exploitation of C. albicans mutants that are unable to form hyphae or that 
constitutively exhibit a hyphal or pseudohyphal form difficult. Thus, the 
dimorphic transition of S. cerevisiae is an attractive model from which insights can 
be gained to leam more about the transition in other pathogenic fungi. 
Previous work done in the laboratory of Dr. Alan Myers has provided a 
basis for the restilts described here. To date, 14 elm (elongated morphology) 
complementation groups have been isolated by a visual screen for cells that grew 
constitutively as elongated cells on rich mediiam after ethylmethane sulfate 
mutagenesis (6). In these complementation groups, the cell elongation phenotype 
resulted from a single recessive mutation in 13 groups and a single semi-dominant 
mutation in one group. The elongated cell morphology of many elm mutants is 
similar to that of wild type yeast strains xmdergoing pseudohyphal growth in 
response to nitrogen starvation. Each elm mutation causes one or more 
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characteristics of pseudohyphal cells, including elongated cell shape, delay in cell 
separation, a unipolar budding pattern, and the ability to grow invasively beneath 
the agar surface. 
Several elm mutants have been identified. ELMl codes for a novel 
serine/threonine protein kinase homolog (7); this protein kinase contains residues 
that are conserved among all protein kinases, but is not homologous to any 
particular protein kinase. A synthetic phenotype was observed in an elml cdc55 
double mutant. Loss of the product of CDC55, a putative B regulatory subimit of 
protein phosphatase 2A, also resulted in pseudoh5rphal growth. In addition, 
ELM13 which codes for a 10-nm neck filament protein was an allele of CDC12 (6). 
The gene products of the semi-dominant mutation group have been identified; 
these gene products were ppsl, phosphoribosylpyrophosphate synthase, and 
elm4, an allele oigrrl (8). 
Initial characterization of these constitutive elm mutants suggests that 
many pathways may be involved in regulation of pseudohjT)hal growth, in addition 
to the MAPK cascade of the mating response. ELMl codes for a novel protein 
kinase, suggesting that phosphorylation may play an important role in regulation 
of pseudohyphal growth. Targets for mod\alation in pseudohyphal growth include 
pathways regulating cell cycle, cell wall biogenesis, and bud site selection. In 
addition, a pathway in which the signal of nitrogen starvation is perceived may 
exist. Answers to these questions should provide insight relevant to questions of 
cell shape and morphogenesis in S. cerevisiae and other systems as well. 
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Dissertation oi^ anization 
This dissertation includes three papers of which I am the primary author. 
In Chapter 1, the Introduction section includes a review of the literature. Chapter 
2 follows the Introduction and will be submitted for publication in the joTimal 
Molecular and CelMar Biology. Chapter 3 will be submitted for pubhcation in the 
Journal of Cell Biology and Chapter 4 will be submitted to Genes and 
Development. Each paper begins with an Abstract followed by an Introduction 
section. Material and Methods are then listed, followed by a Results section in 
which data are presented. Figures and tables are placed within the Materials and 
Methods and Results sections of each paper shortly after they are mentioned in 
the text. Each paper concludes with a discussion of the data presented and of 
issues which pertain to these results. References cited within a paper are listed 
after the discussion in the paper in which they are cited. A general Conclusions 
chapter is presented after the third paper. References cited within the 
Introduction and Conclusions follow the Conclusions chapter. 
The papers in this dissertation have two authors. Dr. Alan Myers, my 
major professor, and myself. In all these papers, Dr. Myers developed or helped 
develop the general approaches taken. All three chapters were written by me, and 
edited by Dr. Myers. The experimental procedures in all chapters have been 
carried out by me. 
Results presented in this dissertation provide insights into mechanism by 
which the protein kinase Elmlp regulates dimorphism in Saecharomyces cerevisiae 
by use of basic genetic and biochemical techniques. The role of Elmlp in 
pseudohyphal growth was examined; catalytic activity was essential for growth in 
the yeast form. In addition, overexpression of Elmlp affected cell cycle. Possible 
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substrates of Elmlp also were identified by use of the two-hybrid system. These 
findings will serve as a stepping stone for further investigation as to the role of 
Elmlp in pseudohyphal growth. 
In Chapter 2, biochemical characterization of Elmlp revealed that Elmlp 
functions as a serine/threonine protein kinase. Potential substrates of Elmlp 
were also identified. The protein seemingly was tightly regulated as the protein 
had to be overexpressed with an amino terminal protein tag before Elmlp was 
detectable in total protein extracts. 
In Chapter 3, the interaction between Elmlp overexpression and other elm 
mutants was examined as well as the consequences of Elmlp overexpression 
itself on cellular morphology. Overexpression of Elmlp affected progression 
through the cell cycle. Cells were blocked in G1 with arrest of DNA replication and 
spindle pole body duplication, but with continuation of budding. In addition, Elmlp 
overexpression was epistatic to the other elm mutants and PHDl expression on a 
high copy plasmid. 
In Chapter 4, the resxalts of a genetic protein-protein interaction trap 
indicated that Elmlp may play a role in regulation of translation or nitrogen 
metabolism. Proteins that Elmlp seeming interacted with in vivo were the 
products of RPL2B, ribosomal protein 2L; TEFl, elongation factor 1-a; two 
putative phosphoribosyltransferase homologs; HSC82, heat shock protein 90; and 
PFKl, phosphofi*uctokinase 1. Preliminary investigations revealed that Elmlp 
also bound to the RPL2B protein and phosphorylated it in vitro. 
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Chapter 2. BIOCHEMICAL CHAEACTERIZATION OF Elmlp, A PROTEIN 
KINASE THAT REGULATES DIMORPHISM IN 
SACCHAROMYCES CEREVISIAE 
A paper to be submitted to Molecular and Cellular Biology 
Carla M. Koehler and Alan M. Myers 
Abstract 
The product of the Saccharomyces cerevisiae gene ELMl (Elmlp) is a novel 
serine/threonine protein kinase that regulates morphologic differentiation. Elmlp 
is likely to be a downstream effector of pseudohyphal growth, because deletion of 
two genes required for this process, STE7 and STEll, did not suppress the 
constitutive pseudohyphal growth phenoiype of an elml-1 mutant. To 
characterize the biochemical activity of Elmlp, various tagged versions of the 
protein were overexpressed and purified fi-om yeast and insect cells. In 
biochemical analyses Elmlp phosphorylated histone HI and H2b, myelin basic 
protein (MBP), and casein in vitro. Elmlp also autophosphorylated on serine and 
threonine residues in vitro. Catalytic activity was lost when Lys^''^ was changed 
to Argll'^, and this mutation also eliminated gene fimction. Elmlp is likely to be 
regulated at a translational or post-translational level, because effective 
monoclonal and polyclonal antibodies failed to detect Elmlp in cells, even when 
transcripts coding for ELMl were overexpressed. Functional versions of Elmlp 
with an amino terminal fusion were detected in cells when the corresponding genes 
were expressed from a synthetic promoter using the GALl UAS. In vitro 
phosphorylation experiments revealed the sizes of several proteins from yeast 
cells phosphorylated by Elmlp. 
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Introduction 
Saccharomyces cerevisiae is a pleimorphic asomycete; Two forms in which S. 
cerevisiae exists are the yeast form and the pseudohyphal form (3, 5, 8,10). The 
yeast form is characterized by oval shape and by tmicellularity. In pseudoh3T)hae, 
the cells have an elongated shape and stay attached to each other presumably by 
their cell walls. The budding pattern is unipolar in which daughter cells bud and 
rebud at the pole opposite their birth pole. This resulting change produces a 
filamentous, branched structure growing away from the center of the colony. In 
addition, pseudohyphal cells are able to penetrate the agar. The switch in 
morphology from yeast form to pseudohyphal form can be induced by nitrogen 
starvation in the presence of glucose (8). 
The gene ELMl is proposed to code for a fimction that, in conditions of 
ammonia limitation, acts in the series of events that result in conversion of the 
yeast form to the pseudohyphal form (2, 3). Recessive elml mutations cause a 
mutant growth state characterized by the formation of expanded, branched 
chains of elongated cells with enhanced ability to grow invasively imder the 
surface of agar media. This phenotype, identical in several regards to 
pseudohyphal colonies of laboratory reference strains growing in low ammonia 
medium, occxirs regardless of the nutrient conditions and independent of solid 
medium. Thus, the phenotype caused by elml mutations is referred to as 
constitutive pseudohyphal growth. 
ELMl was isolated and shown to code for a novel protein kinase homolog (3, 
12,13). The ELMl coding region is 1,689 bp and codes for an open reading fi:ame 
of 563 amino acids. The protein kinase domain is near the amino terminus fi'om 
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amino acids 85 to 400, In a comparison of the Elmlp sequence with other protein 
kinases, Ehnlp appeared roughly equally diverged from all serine/threonine 
protein kinases; thus, Elmlp seemingly is not related to general protein kinase 
families such as those in the MAPK cascade, PKC family, PKA family, and CDK 
family. Elmlp is 23.7% identical to Cdc28p (also known as p34 or histone kinase) 
(22) and 23.1% identical to bovine cAMP-dependent protein kinase cAPK-a (34). 
In addition, the 14 invariant residues found in almost every protein kinase (12,13) 
are also conserved in Elmlp. Based on homology to regions in subdomain VI and 
VIII, ELMl codes for a serine/threonine kinase. The amino and carboxy terminal 
regions of Elmlp, however, are not homologous to any proteins identified to date. 
Components of the pheromone response pathway are required for 
pseudohyphal growth in diploids and invasive growth in haploids (21,27). In diploid 
strains competent to grow as pseudohypae in nitrogen starvation conditions, 
mutations in STE2, STE3, STE4, STE18, KSSl, and FUSS had no discernible 
effect on pseudohyphal growth. In constrast, mutations in STE20, STEll, STE7, 
and STE12 suppressed the formation of pseudohyphae and invasion into the agar 
mediimi (21). In haploid cells, invasive growth reqmres STE20, STEll, STE7, and 
STE12 (27). The role oiKSSl and FUSS however is complex and may suggest the 
existence of other MAP kinases specific for this pathway. Particularly, kssl 
FUSS mutants are defective for invasiveness, and KSSl fusS mutants exhibit 
enhanced invasiveness (27). Mutants defective in both genes exhibit normal 
invasiveness. 
In this study, we sought to order the site of action of Elmlp in a presumed 
cascade of events controlling pseudohjrphal differentiation, relative to other genes 
known to be required for pseudohyphal growth. Elmlp seemingly fimctions 
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downstream of the MAP kinase cascade involving STE7 and STEll in regulation 
of pseudohyphal differentiation. Because the MAP kinase cascade module 
typically represents a functional unit of a signalling process (14), it is likely that 
Elmlp may be a close effector to some parts of the pseudohyphal differentiation 
response. To investigate further the action of Elmlp, the protein was purified and 
characterized with regard to its protein kinase activity. 
Materials and Methods 
Strains and media. S. cerevisiae strains used in this study are described in 
Table 1. Strain Y690 contained the plasmid pMA210 (23), which has been 
renamed pHIS3GAL4 (Table 2). In this plasmid, GAL4 was expressed from the 
ADHl promoter in a vector with the HISS marker and 2)1 origin of replication; the 
presence of pHIS3GAL4 in strain Y690 insiared that levels of Gal4p were 
adequate. Strain Delml-l was disrupted with ste7::URA3 and stell::URA3 
(provided by B. Errede) by standard procediires (1). 
Yeast strains were cultured at 30®C. The following media were used: YPD 
(1% yeast extract, 2% peptone, 2% glucose); SD (2% glucose, 0.7% yeast nitrogen 
base without amino acids, supplemented as required with leucine, tryptophan, 
histidine, lysine, uracil, methionine, and adenine at 20 ng/ml each); SG (2% 
galactose, 0.7% yeast nitrogen base without amino acids, supplemented as needed 
with auxotrophy requirements listed above); SR (2% raffinose, 0.7% yeast 
nitrogen base without amino acids, supplemented as needed with auxotrophy 
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requirements listed above). Solid media for yeast contained 2% agar. Yeast 
strains were transformed using the LiCl procedure (33). 
Nucleic acid manipulations. Recombinant DNA manipulations were 
performed using standard procedures (1, 30). Yeast RNA was isolated using a 
Table 1. S. cerevisiae strains 
Strain Genotype Source or 
derivation 
W303 MATa ura3 leu2 his3 trpl ade2 R. Rothstein 
aWAelmlH MATa ura3 leu2 hisS trpl ade2 
elml::HIS3 
M. Blacketer 
Y690 MATa! a Ieu2lleu2 ura3lura3 
his3lhis3 [pHIS3GAL4] 
R. Deschenes 
Delml MATa met6 ura3 elml-1 M. Blacketer 
Delml ste7 MATa metS ura3 elml-1 
ste7::URA3 
This study 
Helml stell MATa metS ura3 elml-1 
stell::URA3 
This study 
Y690 background: 
Y690[pCK35] 
Y690[pBM150] 
Y690[pCK36] 
Y690[pCK77] 
Y690[pCK36-Tl] 
Y690[pCK36-T2] 
W303 background: 
W303[pCK35] 
W303[pBM150] 
aWA€ZmIH[pCK35] 
aWAeZmi/?[pBM150] 
aWAeZm2H[pCK36] 
aWAeZm2H[pCK77] 
aWAe/mIi?[pCK36-Tl] 
aWAeZmiH[pCK36-T2] 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
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Table 2. Plasmids constructed in this study. 
Name Insert Allele SoTirce Cloning vector 
pHIS3GAL4 3.5 kb VADHI-GAIA pMA210 (23) 
HINMUHINMI 
pCK20 0.8 kb trpE-ELMl pAl pATH21 (18) 
PstVEcdRl 
pCK26 1.25 kb lacZ-ELMl pAl pUR292 (29) 
PstVHindm 
pST9 0.65 kb ELMl pA2 pUC119 (37) 
HindlJUPstl 
pCK24 0.28 kb ELMl ST9 pGEM-5Zf+ 
NdeVPstl (Promega) 
pST16 3.0 kb ELMl pAl pBSS/K 
SstUSall (Stratagene) 
pCK29 0.28 kb ELMl pCK24 pST16 
SstVPstl (pBS S/K) 
pCKSO 2.2\ihSstVKpnlELMl pCK29 pUC118 (37) 
pCK34 BarriHl linker ELMl pCK30 pCK30 
at N terminus (pUC118) 
pCK35 2.2 kb ELMl pCK34 pBM150 (15) 
BaniHlJBamWL 
pCK37 BamHL linker ELMl pCK30 pCK30 
at N terminus (pUC118) 
pCK36 2.2 kb GST-ELMl pCK37 pEGST (24) 
BamBUSall 
pCK36-Tl - 0.21 kb GST-ELMl pCK36 pEGST 
HINAMJHINEIA. 
pCK36-T2 -0.4 kb GST-ELMl pCK36 pEGST 
SPEVHINEM 
pCK75 - Pstl site ELMl pCK37 pCK30 
KpnVSphl 
eZmiArgll7 
(pUC118) 
pCK76 1.2 kb YCpelml pCK75 
PstVBgm 
eZm2Argll7 
(pUC118) 
pCK77 2.2 kb pCK76 pEGST 
BarriHUSall 
pCK45 2.2 kb ELMl pCK37 pBlueBacHisA 
Ba/nHI/BamHI (Invitrogen) 
28 
glass bead lysis procedvire (1). Oligonucleotide-directed site-specific mutagenesis 
iised the phosphothiolate method (32). Nucleotide sequence analysis used the 
chain termination method (31) with Sequenase (USB, Cleveland, OH). 
Immunoblot analysis used the ECL chemiluminscence system (Amersham, 
Arlington Heights, IL) according to manufacturer's suggestions. Antibodies anti-
GST (Molecular Probes, Eugene, OR), anti-T7 (Novagen, Madison, WI) and anti-
Elmlp (see below) were used for detection of Elmlp. E. coli strain TGr-1 
(Amersham, Arhngton Heights, IL) was used for amplification of plasmids and 
single-stranded DNA production. 
Preparation of Elmlp-specific antibodies. The 800 bp PstVEcoBl 
fi*agment of ELMl containing codons 94-362 was ligated in frame to the amino 
terminal coding region of the E. coli trpE gene in vector pATH21 (18) forming 
plasmid pCK20 (Table 2). E. coli transformants harboring pCK20 expressed a 
fusion protein of approximately 59 kD when the trpE promoter was induced (18) in 
agreement with the expected molecular weight of the fiision protein based on the 
sequence of ELMl and trpE. The fusion protein was recovered quantitatively in 
the insoluble fraction of E. coli. For immunization approximately 200-400 jig of 
fusion protein was collected in a strip excised from a 10% SDS-polyaciylamide gel, 
crushed in phosphate-biiifered saline (PBS) bufier (10 mM KPO4, pH 7.4,150 mM 
NaCl), mixed with complete Fretmd's adjuvant, and injected subcutaneously and 
intramuscularly into New Zealand white rabbits. Booster injections of 200 |ig 
were administered four and six weeks after primary inmiunization. Blood was 
collected before primary injection, and one week after each booster injection. 
Most immunoblot analyses were done with crude antiserum against the 
trpE-ELMl fusion protein, denoted anti-Elmlp; antibodies specific for Elmlp also 
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were purified from the crude antiserum by affinity chromatography (6). This was 
accomplished by subcloning a 1,270 bp PstVHindlll fragment of ELMl containing 
codons 94-520 in frame to the amino terminal coding region of the LacZ gene in 
vector pUR292 (29) to construct plasmid pCK26. pCK26 in strain TG-1 was 
induced from the lac promoter and total cell lysate was prepared. Using 
immimoblot analysis, an anti-J3-galactosidase (Sigma Chemical Co., St. Louis, 
MO) antibody cross-reacted with a protein of 160 kD which was the predicted 
molecular weight of the lacZ-ELMl fusion protein. An affinity matrix coupling the 
lacZ-ELMl protein product to Sepharose CL-4B (Pharmacia Inc., Piscataway, 
NJ) through monoclonal antibodies specific for J3-galactosidase (Sigma Chemical 
Co., St. Louis) was prepared as described by Carroll and Laughon (6). Crude 
antiserum from rabbits immunized with the trpE-ELMl product was passed over 
the affinity matrix, the column was washed extensively with PBS and bound IgG 
was eluted in 4M guanidine-HCl and dialyzed against PBS. 
Allele construction. The plasmid pCK35, in which ELMl was placed 
downstream of the GALl promoter to form GAL::ELM1, was constructed as 
follows (Table 2). A 650 bp HinWUPstl fragment from pA2 (3) was ligated into 
pUC119 (37) to form ST9. ST9 was used as a PCR template to place an Ndel site 
at the ATG site in ELMl. The mutagenic primer CKl, 5'-
ACTTAGCATATGTCACCG-3', and M13 forward sequencing primer (New 
England Biolabs, Beverly, MA) were used to amphfy a 280 bp fragment. 
Conditions for PCR amplification were an initial cycle at 94-C for 3 min, followed 
by 30 cycles of 94-C for 1 min, 47-C for 1 min, and 72®C for 1 min, and one final 
cycle of 72°C for 15 min. The PCR amplified fragment was digested with NdeJJPstl 
and subcloned into pGEM-5Zf+ (Promega Corp, Madison, WI) to construct pCK24. 
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Mutagenesis was confirmed by sequencing with primer CK2, 5'-
GAGCGTTATCGGG-3' to cross the ATG site in ELMl, ST16 was constructed by 
subcloning the ELMl gene as a 3.0 kb SstVSall fragment from pAl (3) into 
pBLUESCRIPT S/K (Stratagene, La Jolla, CA). The SstVPstl fragment 
containing the first 280 bp and promoter region of ELMl from ST16 was replaced 
with the 280 bp SstVPstl fragment from pCK24 to construct pCK29. The entire 
ELMl gene was removed from pCK29 as a 2,200 bp SstUKpnl fragment and 
ligated into vector pUC118 (37), resulting in the plasmid pCK30. A BaniSl site 
was placed upstream of ELMl by digesting pCK30 with Sstl, filling in the ends 
with T4 DNA polymerase and inserting a BamHl linker to construct pCK34, 
Insertion of the BamHl site was seven nucleotides upstream of the ELMl start 
codon, which was confirmed by sequencing with primer CK2. From pCK34 a 
2,200 bp BamHl fragment was excised and ligated into pBMlSO (15) to construct 
pCK35. 
The plasmid pCK36, in which the gene glutathione S-transferase (GST) was 
fiised to the amino terminus of ELMl to form GAL::GST-ELM1 was constructed 
as follows (Table 2). A BamHl site was placed upstream of ELMl by digesting 
pCK30 with Sstl, filling in the ends with T4 DNA polymerase and inserting a 
BamHl linker to construct pCK37. The BamHl site was placed correctly, as 
determined by sequencing with primer CK2, just 5' of the second codon in Elmlp 
for fiision in frame to GST in vector pEGST (provided by R. Deschenes, University 
of Iowa) (24). A 2,200 bp BamHl/Sall fragment from pCK37 was excised and 
ligated into pEGST to construct pCK36. In this plasmid, Elmlp was expressed as 
a GST-ELMl fiision from the CYCl promoter xmder control of a galactose-
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inducible upstream activator sequence (GALl-lOUAS) (9); vector pEGST also 
contained a 2^ origin of replication and URA3 and leu2-d alleles. 
Two GAL::GST-ELM1 truncation alleles were constructed. Plasmid pCK36 
was digested with HmdIII to remove 43 amino acids from the carboxy terminus 
and religated to construct pCK36-Tl. Plasmid pCK36 was digested with Spel and 
Hindlll to remove 100 amino acids from the carboxy terminus, filled in with T4 
polymerase, and religated, forming pCK36-T2. 
The plasmid pCK77, which contains a missense allele fused 
downstream of GST, was constructed as follows. Plasmid pCK37 was cleaved 
with Kpnl and SphI, filled in with T4 polymerase, and re-ligated to remove a Pstl 
site from the mxiltiple cloning region upstream of ELMl to construct pCK75. A 
1,180 bp PstUBgllL fragment from YCpelml (3) containing the ArgH'^ mutation 
replaced the wild-type sequence in pCK75 forming plasmid pCK76. The 2,200 bp 
BaniHl fragment from pCK76 containing was ftised in frame to 
construct pCK77. 
Functional analysis of ELMl in yeast. ELMl alleles were tested for 
functionality based on their ability to restore the constitutive pseudohyphal 
phenotype of elml to the yeast-form as follows. Strain a^t^elmlH (3) was 
transformed with the ELMl alleles pCK35, pCK36, and pCK77 and controls 
pBMlSO and pEGST to uracil prototrophy. Transformants were patched on SD 
lacking uracil or SG lacking uracil; the phenotype was scored by examination of 
individual cells three to four hours after patching. Cells were suspended from an 
agar dish in a drop of 1.2 M sorbitol or distilled water and observed at 400X 
magnification using Nomarski optics. 
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Expression and purification of GST-ELMl hybrid proteins from 
yeast cells. Yeast strain Y690 was transformed with pBMlSO, pCK35, pEGST, 
pCK36, pCK36-Tl, or pCK36-T2 to uracil prototrophy. Cultures were grown to a 
density of 1 x 10^ cells/ml in SR lacking uracil, histidine, and leucine, and protein 
expression was induced by addition of galactose to 4% (v/v). Total protein was 
prepared as described previously (24). Specifically, after induction of 8-12 hours, 
cells were harvested by centrifugation and washed once with sorbitol buffer (0.3 M 
sorbitol, 0.1 M NaCl, 5 mM MgCl2,10 mM Tris, pH 7.4). Approximately 1 x 10^ 
cells were resuspended in 500 |j1 sorbitol buffer containing 1 mM PMSF and 2 
Hg/ml each of the proteinase inhibitors, leupeptin, aprotinin, pepstatin, and 
chymostatin A. Approximately two-thirds volume of glass beads (425-600 |im 
diameter, Sigma Chemical Corp., St. Louis, MO) was added. Cells were broken by 
vortexing for one min intervals interrupted with 1 min chilling intervals at 4-C 
until 75% of the cells were broken. Celltdar debris was removed by centrifugation 
at 4000 xg for five min at 4®C. Soluble and membrane firactions were separated 
by centrifugation at 100,000 xg for 15 min at 4-C two times. For immunoblot 
analysis, 50 ^ig of supernatant were set aside. For purification, lysates were 
incubated with 50 |j1 of a 50% slurry of glutathione agarose (Sigma, St. Louis, MO) 
at 4®C with gentle shaking for 30 min. The beads were washed six times with 
PBS. After washing, the beads were resuspended in 50 |jI of IX Laemmli loading 
buffer for immxmoblot analysis or resxispended in 50 |j1 PBS for phosphorylation 
assays. 
Cell culture. S. frugiperda Sf21 insect cells (Life Technologies, 
Gaithersburg, MD) were grown at 27-C in Grace's Antheraea mediimi with 5% 
fetal bovine senim (Life Technologies, Gaithersburg, MD) or Sf900II-serum free 
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medium (Life Technologies, Gaithersburg, MD). Procedures used for cell ctalture, 
baculovirus infection and isolation of viral genomic DNA have been described (1, 
16, 35). Specific procedures are listed in the Appendix. 
Generation of recombinant baculovirus construct. The recombinant 
baculovirus transfer gene fusion pCK45 was constructed by excising a 2,200 bp 
BamRl fragment from pCK37 and ligating into pBlueBacHisA (Invitrogen Corp., 
San Diego, CA). An amino-terminal tag of six histidines and 15 amino acid peptide 
from the amino terminus of T7 gene 10 were fused in frame to the amino terminus 
of ELMl. The T7 gene 10 fragment was present for transcript stabilization and 
as a tag for detection with monoclonal anti-T7 (Novagen, Madison, WI). The 
construct was sequenced using primer CK2 to confirm that ELMl was in frame. 
Recombinant baculovirus ELMl-XP resulted from co-transfection of Sf21 cells 
with 1 |ig wild-type bacialoviral DNA and 2 |ig pCK45 (35) and purification of 
recombinant baculovirus (1,16, 35). Recombination was confirmed by Southern 
analysis vismgELMl as a probe. The recombinant virus was purified from wild-
type virus (WTV) by three rovmds of plaque purification. 
Purification of Elmlp £rom insect cells. Cultures of Sf21 cells (5 x 10^ 
cells) were harvested 48 hr after infection with recombinant baculovirus ELM-XP. 
The infected cells were pelleted, washed with PBS, and lysed at 4®C with 10 ml of 
lysis bufier (20 mM HEPES, pH 7.5, 5 mM MgCl2,0.5% NP-40,1 mM PMSF, and 
2 pg/'ml each of the proteinase inhibitors, leupeptin, aprotinin, pepstatin, and 
chymostatin A). The lysate was clarified by centrifiigation at 10,000 xg for 10 
min. EDTA was added to a final concentration of 2 mM. 
Chromatography columns were connected to a low pressure 
chromatography system (Bio-Rad Laboratories, Hercules, CA) at 4°C. Clarified 
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lysate was applied at a flow rate of 2.5 ml/min to a 25 ml SP Sepharose 
(Pharmacia, Piscataway, NJ) column equilibrated with Buffer A (20 mM Hepes, 
pH 7.5,1 mM PMSF). The column subsequently was washed with 75 ml Buffer A 
followed by a 175 ml linear gradient of Buffer A with 1.3 M NaCl. Three ml 
fractions were collected. Fractions containing Elmlp, identified by immimoblot 
analysis with anti-Elmlp or anti-T7 tag and by phosphorylation activity, were 
combined and applied at a flow rate of 1 ml/min over a 0.5 ml Ni+2 agarose coliram 
(Qiagen, Chatsworth, CA) equilibrated with Buffer B (20 mM NaP04, pH 7.5, 500 
loM NaCl, 1 mM PMSF). The column subsequently was washed in steps with 20 
ml Buffer C (20 mM NaP04, pH 6.3, 500 mM NaCl, 1 mM PMSF), 20 ml Buffer C 
with 50 mM imidazole, and 20 ml Buffer C with 100 mM imidazole. Elmlp was 
eluted with 20 ml Buffer C with 500 mM imidazole and collected in 1 ml fractions. 
Elmlp was detected by immimoblot analysis and phosphorylation activity. As a 
control, lysate from WTV-infected insect cells was purified using the same 
procedure. 
Phosphorylation assays. Aliquots containing Elmlp from insect cells or 
GST-ELMl hybrid protein immobilized on glutathione agarose and controls were 
assayed for kinase activity. Three nl (100-500 ng) of a fraction of purified Elmlp 
from insect cells or 20 |j1 (100-500 ng) of a 50% slurry of purified GST-ELMl 
hybrid protein from insect cells were incubated in a 30 pi reaction volume 
containing 40 mM Tris-HCl, pH 7.5,1 mM dithiothreitol, 10 mM MgCl2,5 mM 
NaF, 1 mM ATP (7,000 Ci/mmol, 8.5 |iCi/30 nl reaction) (ICN, Costa 
Mesa, CA) at 30®C for 30 min for autophosphorylation assays. The 
phosphoacceptors assayed were histone HI (4 mg/ml), histone H2b (1 mg/ml), 
casein (1 mg/ml), myelin basic protein (MBP, 1.5 mg/ml), and phosphorylase b (1 
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mg/ml). All substrates were purchased from Sigma Chemical Corp (St. Louis, 
MO) with the exception of phosphorylase b (provided by Don Graves, Iowa State 
University). The reaction was stopped by addition of 4X LaemmK loading bioffer 
(20). In reactions with yeast protein as a substrate, protein was isolated from 
strain aWAelmlH using the glass bead lysis procedure. Endogenous kinase 
activity was inactivated by heating the protein sample at 70-C for 10 min and 
lysate was added at 6 mg/ml in each reaction. 
Phosphoaminoacid analysis. Ebnlp or controls from 
autophosphorylation reactions were precipitated in 20% TCA with 20 ixg/ml 
RNAse and prepared for separation on a Hunter thin-layer electrophoresis vinit 
(CBS Scientific, Del Mar, CA) according to published procedures (4). 
Polyacrylamide gel electrophoresis and autoradiography. Protein 
samples and phosphorylation assays were separated on 10% SDS-polyacrylamide 
gels (20). The gels were stained with Coomassie Blue R-250 and destained in 7.5% 
acetic acid, 5% methanol. Gels were dried vmder vacuixm and exposed on Kodak 
XAR-5 film for autoradiography. 
Results 
Deletion of STE7 and STEll did not affect the constitutive 
elongated cell morphology of elml. To determine whether STE7 and STEll 
fimction upstream of ELMl, double mutants elml ste7 and elml stell were 
constructed and disruption of the mating pathway genes was confirmed by 
Southern blot analysis. Deletion of STE7 or STEll prevents a wild type yeast 
strain from growing as pseudohyphae in low ammonia medium (21). However, 
deletion of STE7 and STEll did not affect the constitutive pseudohyphal growth 
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of the elml mutant on rich media (data not shown). Thtis, STE7 and STEll 
seemingly function upstream of ELMl or fimction in a different pathway. 
Production of anti-Elmlp. To detect Elmlp in yeast cells, polyclonal 
antibodies, termed anti-Elmlp, were raised against a hybrid polypeptide 
consisting of Elmlp residues 94-362 fused to component I of anthranilate 
synthetase, the product of the E. coli trpE gene. The fusion protein was produced 
in E. coli jfrom the hybrid gene trpE-ELMl, partially purified by SDS-PAGE, and 
used to inoculate rabbits. A subset of the antibodies specific for Elmlp were 
purified fi*om the resulting serum using an affiniiy column crosslinked with a lacZ-
ELMl fusion protein, in which Elmlp codons 94-520 were fused to the E. coli lacZ 
gene (6). The specificity of the crude antibody preparation was tested by 
immunoblot analysis. Anti-Elmlp specifically detected a 59 kD protein, 
correlating to the predicted molecular weight of the trpE-ELMI hybrid protein, in 
IPTGr-induced cells expressing the trpE-ELMI hybrid protein (Fig. lA). In addition, 
a 160 kD protein was detected by anti-Elmlp in IPTG-induced cells expressing the 
allele lacZ-ELMl, which was the same as the predicted molecular weight of the 
hybrid fusion protein (Fig. IB). In cells expressing the trpE-ELMI hybrid protein, 
smaller protein products also were detected by anti-Elmlp. Polyclonal antibody 
anti-Elmlp detected Elmlp fusion proteins in E. coli lysates from IPTG-induced 
cells. 
To determine if full-length Elmlp could be expressed in E. coli, gene fusions 
were constructed in which ELMl was placed in various E. coli expression vectors. 
However, using anti-Elmlp in immunoblot analysis, Elmlp was not detectable in 
total protein lysates firom E. coli ceUs induced to express ELMl (data not shown). 
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Figure 1. Expression of Elmlp fusion proteins inE. coli and detection with 
anti-Elmlp. Bacterial cultures with alleles trpE-ELMl or lacZ-ELMl were 
induced by addition of IPTG to express part of Elmlp fused in frame to 
anthranilate synthase or J3-galactosidase, respectively; total cellxilar lysate was 
prepared and separated by SDS-PAGE for immunoblot analysis with anti-Elmlp. 
Crude anti-Elmlp was used for immimoblot analysis. (A) Immxmoblot analysis of 
total lysate from strains containing pCK20 with the trpE-ELMI allele and the 
empty vector pATH21 (18). (B) Immunoblot analysis of total lysate from strain 
containing pCK26 with the lacZ-ELMl allele. 
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Native Elmlp was not detectable in yeast cell lysates. To determine if 
native Elmlp was present in total protein lysates from wild-type yeast cells, 
immunoblot analysis was performed with anti-Elmlp. Unfortiinately, endogenous 
Elmlp was not present at levels that were detectable in immunoblot analysis 
(data not shown). In addition, in Northern analysis using purified mRNA from 
wild-type strain W303, ELMl mRNA was detectable only after overexposure for 
several days (data not shown). Thus, the level of the ELMl transcript and Elmlp 
in wild-type cells was extremely low. 
To increase the transcription rate of the ELMl coding region, the native 
promoter was replaced with the strong, inducible promoter of the GALl gene (15). 
The centromeric, autonomously replicating plasmid pCK35 contained the gene 
fusion GAL::ELM1 (Fig. 2, Table 2)(15); plasmid pCK35 was transformed into 
wild-type strains Y690 and W303 and control ELMl null strain aW^lmlH and 
produced a protein termed Elmlp (Table 1). During growth in glucose or raffinose 
media, the wild-type strain with GAL::ELM1 in which native Ehnlp was expressed 
was expected to contain the wild-type level of Elmlp, whereas during growth in 
galactose media the strain was expected to produce a high level of Elmlp. To 
establish that functional Elmlp cotdd be produced, Northern analysis was 
perfomed to determine that the ELMl transcript was present and was the 
expected size specifically under inducing conditions. From cells grown in glucose 
media, the ELMl transcript in strain W303[pCK35] essentially was not 
detectable in total RNA with ELMl as a probe (Fig. 3A). However, in total RNA 
isolated from the strain grown in the presence of galactose, a transcript of 2,000 
nucleotides was detected specifically with an £?LMi probe (Fig. 3A); the length of 
this transcript corresponded to the predicted size of the ELMl transcript. 
Figure 2. Diagrams of protein constructs for Elmlp expression in yeast and insect cells. The deduced 
amino acid sequence of Elmlp is aUgned with a Kyte-Doolittle (19) hydropathy plot calculated jfrom the Elmlp 
sequence and with Elmlp protein constructs. In the Elmlp sequence, the protein kinase domain is designated 
by the hatched region and two PEST regions are designated by the black regions. The gene fiisions were 
constructed as described in the Materials and Methods. pCK35, based on vector pBMlSO (15), contained 
GAL::ELM1 and expressed Elmlp in vector pBMlSO . In pCK36, vector pEGST (24) contained gene fusion 
GAL::GST-ELM1 and expressed GST-Elmlp. pCK77 was identical to pCK36 with the exception that Lys^^'' 
has been mutated to ArgH*^. pCK36-Tl and pCK36-T2 were identical to pCK36 except that the carboxy 
terminal 43 amino acids and 100 amino acids have been removed from Elmlp, respectively. In pCK45, ELMl 
was tagged at the amino terminus with a hexa-histidine cassette and 15 amino acids from T7 gene 10. This 
construct was co-transformed with WTV into insect cells and recombinant virus ELMl-XP was purified; in 
ELMl-XP, tagged ELMl replaced the polyhedrin coding region and was controlled by the polyhedrin promoter. 
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Figure 3. Analysis of ELMl RNA and cell morphology of an elml strain 
overexpressingSLMJ gene fusions. (A) The presence of the ELMl transcript 
was examined in wild type strain W303[pCK35] and strain 
aWAelmlH[pCK35] by Northern analysis with ELMl as a probe; both strains 
expressed Elmlp trader control of the GALl promoter. Strains were induced as 
described in the Materials and Methods. RNA was isolated 8 hoiars after 
induction and prepared by glass bead lysis; approximately 5 mg of total RNA 
from each strain was analyzed. (B) Steain aWAelmlH transformed with 
ELMl gene ftisions was patched on SD and SG; after four hours, cells were 
resuspended in water, and photographed by Nomarski optics. (1) 
aWAeZmiHCpEGST] expressing GST protein on SG; (2) aWAeZmii3IpCK35] 
expressing Elmlp on SG; (3) aWAeZmlff [pCK36] expressing GST-Elmlp on 
SG; (4) aWAeZ/niH[pCK36-T2] expressing GST-Elmlp-T2 on SG 
(aWAeZmIi3TpCK36-Tl] on SG is identic^); (5) aWAeZmliilpCK??] expressing 
GST-Ehnlp^gll7 on SD; (6) aWAeZmI£r[pCK77] on SG. Strain 
aWAcZmiJiZtpCK77] on SD is representative of all aWAelmlH strains on SD 
that were not shown. 
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To establish that functional Elmlp was produced from the gene fusion 
GAL::ELM1, the ability of Elmlp to complement the constitutive pseudohyphal 
phenotype of aWAalmlH, in which the ELMl gene has been replaced, was 
examined. After growth on glucose media, cells in strain aWAeZm2i?[pCK35] grew 
as pseudohyphae constitutively (identical to Fig. 3B-5). Cells in strain 
aWAeZmiH[pCK35] containing gene fusion GAL::ELM1 grew in yeast-like 
morphology, characterized by uniform oval cells, in galactose media (Fig. 3B-2); 
this change is phenotype was visible fotir hours after plating on galactose media. 
Hence, the ELMl transcript was present and Elmlp was functional in vivo when 
cells were grown in the presence of galactose. 
To determine if Elmlp was detectable in strains expressing GAL::ELM1, 
immunoblot analysis was performed on total yeast lysates with anti-Elm Ip. 
Total protein extracts were prepared from strains W303[pCK35] and 
Y690[pCK35], each expressing Elmlp imder control of the GALl promoter; 
Elmlp was not detectable in lysates from galactose-induced cells by immxmoblot 
analysis using anti-Elmlp (Fig. 5A, described in detail later). To establish that 
anti-Elmlp was a satisfactory antibody, another gene fusion identical to pCK35 
was constructed in which an HA epitope (7) was fiised to the carboxy terminvis of 
GAL::ELM1. In immimoblot analysis with monoclonal antibody 12CA5 (BAbCo, 
Berkeley, CA), which was specific for the HA epitope, Elmlp was not detected in 
lysates from galactose-induced cells (data not shown); control proteins tagged with 
HA were identified with antibody 12CA5. Although the ELMl transcript was 
present and Elmlp was functional in vivo, the protein was not detectable by 
immunoblot analysis using anti-Elmlp or monoclonal antibody 12CA5. 
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Overexpression and purification of Elmlp in insect cells. Becatise 
native Elmlp was not detectable in yeast when placed downstream of the GALl 
promoter and Elmlp was not detectable when expressed in various E. coli 
expression systems, Elmlp was expressed using the baculovirus/insect cell 
expression system (1,16, 35). Recombinant baciilovirus ELMl-XP, in which 
ELMl was tagged at the amino terminus with a hexa-histidine cassette and 15 
amino acids from T7 gene 10 in construct pCK45 (Fig. 2, Table 2), was used to 
infect Sf21 insect cells. The location of ELMl downstream of the polyhedrin 
promoter in ELMl-XP was confirmed by Southern analysis (data not shown). A 
time course analysis from 12-96 hours post-infection was performed on nuclear 
and cytoplasmic fractions isolated from ELMl-XP-infected insect cells (data not 
shown). A 70 kD protein was detected predominately in the cytoplasmic fraction 
in immunoblot analysis with monoclonal anti-T7 or anti-Elmlp; the predicted 
molecular weight of Elmlp from ELMl-XP was 65 kD. This protein was not 
detected in c3d;oplasmic fractions isolated from WTV-infected insect cells. Elmlp 
levels were highest at 48 hours post-infection; with continued expression, the level 
of Elmlp remained the same and products of lower molecular weight were 
observed. 
Elmlp was purified from insect cell lysates as described in the Materials 
and Methods. As a control, lysate from "WTV-infected insect cells was subjected to 
the identical purification scheme. In immunoblot analysis of total lysate, anti-T7 
detected a single protein of 70 kD (Fig. 4A). Total lysate first was applied to a 
cation exchange coliman, followed by elution of proteins with an increasing salt 
gradient. A 70 kD protein, Elmlp, was present in fractions 24-36 as detected by 
immimoblot analysis with anti-T7 (Fig. 4B). Proteins smaller than 70 kD also 
Figure 4. Purification of Elmlp from insect cells infected with recombinant baculovirus ELMl-XP. 
Insect cell were harvested 48 hours after infection with recombinant bacxilovirus ELMl-XP and cellvilar lysate 
was prepared and purified as described in the Materials and Methods. Lysate firom WTV-infected insect cells 
served as a control. (A) Total lysate fi-om ELMl-XP cells was examined by immunoblot analysis with anti-T7. 
(B) Fractions eluted from SP Sepharose column were analyzed for Elmlp by immunoblot analysis with anti-T7 
and by kinase activity. For kinase assays, 3 |xl of a fi'action was incubated with histone HI (4 mg/ml) in 40 mM 
Tris-HCl, pH 7.5,1 mM dithiothreitol, 10 mM MgCl2, 5 mM NaF, 1 |iM [g-32p] ATP (7,000 Ci/mmol) at 30=0 for 
30 min. (C) Fractions eluted fi'om the Ni+2 agarose column were analyzed for Elmlp by immimoblot analysis 
with anti-T7 and by kinase activity. Kinase assays were identical to those described in B, 
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were identified by anti-T7; most likely, these were degradation products because 
anti-T7 recognizes residues at the amino-terminus of Elmlp. In addition, the 
presence of Elmlp corresponded with an increase in histone HI kinase activity 
(Fig 4B); kinase activity was significantly greater in fi'actions of lysate purified 
fi:om ELMl-XP-infected insect cells than WTV-infected insect cells (Fig. 4B). 
Fractions 24-36 were pooled, applied to a Ni+2 agarose column, and eluted with 
step washes of increasing imidazole. After elution with 500 mM imidazole, Elmlp 
was present in fi'actions 7-11 as detected by immunoblot analysis with anti-T7 
(Fig. 4C). Once again, the presence of Elmlp correlated with an increase in 
histone HI kinase activity (Fig. 4C), whereas kinase activity in fractions from 
WTV-infected lysate was barely detectable (Fig. 4C). In all cases, immimoblot 
analysis with anti-Elmlp gave the same results as immunoblot analysis with 
anti-T7. Thus, recombinant Elmlp was expressed and ptirified firom insect ceUs 
and the presence of Elmlp in lysates firom ELMl-XP-infected insect cells 
correlated with an increase in HI kinase activity when compared to lysates fi-om 
WTV-infected insect cells. 
Overexpression and purification of Elmlp in yeast cells. Because 
Elmlp was not detectable in yeast, a GST fiision was placed at the amino 
terminus of Elmlp. The 2|i plasmid pCK36 contained the gene fiision GAL::GST-
ELMl, in which GST was fiised to the amino terminus (Fig. 2, Table 2)(9, 24); the 
promoter in this construct is essentially induced by the presence of galactose 
because the GALl-10 upstream activation sequenced was placed 5' to the CYCl 
promoter (24). Plasmid pCK36 was transformed into wild-type strain Y690 and 
ELMl null strain aWAelmlH and produced a protein termed GST-Elmlp (Table 
1). Induction conditions of GAL::GST-ELM1 in pCK36 were identical to those of 
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GAL::ELM1 in pCK35. To establish that functional GST-Elmlp could be 
produced, Northern analysis was perfomed to determine that the GST-ELMl 
transcript was present and was the expected size specifically under inducing 
conditions. Using ELAfi as a probe, the GST-ELMl transcript was present in 
cultures grown in galactose and was the expected size (data not shown). To verify 
that functional Elmlp was produced fi:om the gene fusion GAL::GST-ELM1, the 
ability of GST-Elmlp to complement the constitutive pseudohj^jhal phenotype of 
aW^lmlH, in which the ELMl gene has been disrupted, was examined. After 
growth on glucose media, cells in strain aWAelmlH[pCKS6] grew as 
pseudohyphae constitutively (identical to Fig, 3B-5). Cells in strain 
aWAeZm2i?IpCK36] containing gene fusion GAL::GST-ELM1 grew in yeast-like 
form, characterized by uniform oval cells, in galactose media (Fig. 3B-3); this 
change is phenotype was visible foxar hours after plating on galactose media. 
Control aWAe/m2fZtpEGST] expressing only the GST protein grew constitutively 
as pseudohjrphae regardless of the carbon source (Fig. 3B-1). Hence, the GST-
ELMl transcript was present and GST-Elmlp was functional in vivo when cells 
were grown in the presence of galactose. 
Because GST-Elmlp was ftmctional in vivo, further analysis was continued 
to determine if the GST-Elmlp protein was detectable. Strains Y690[pCK35], 
containing GAL1::ELM1, Y690[pCK36], containing GAL::GST-ELM1, and control 
Y690[pEGST], containing GST, were grown in the presence of raffinose or 
galactose and total protein extracts were prepared as described in the Materials 
and Methods for immunoblot analysis. A 97 kD protein was detected specifically 
in extract from strain Y690[pCK36] in galactose-induced cells (Fig 5A). This 
corresponded to the predicted molecular weight of the GST-Elmlp protein fusion. 
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Figure 5. Expression and purification of GST-Elmlp in yeast. Strains 
Y690[pCK35], Y690[pCK36], and control Y690[pEGST] were grown in raffinose 
Tuitil a density of 1 x lO'^ cells/ml and then induced by the addition of galactose to 
4% (v/v). Total cell lysate was prepared 8-12 hours after induction by glass bead 
lysis for immunoblot analysis and purification. (A) Immunoblot analysis with 
anti-GST of cell lysate from strain Y690[pEGST] expressing GST and 
Y690[pCK36] expressing GST-Elmlp. (B) Immunoblot analysis with anti-Elmlp 
of cell lysate from strain Y690[pCK35] and Y690[pCK36] grown in galactose. (C) 
Total cell lysate fi'om strain Y690[pEGST] or Y690[pCK36] was incubated with 
50 |il of a 50% glutathione agarose slurry at 4°C for 30 min, followed by washing 
with PBS, and then prepared for immvmoblot analysis with anti-GST and anti-
Elmlp. 
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Proteins smaller than 97 kD also detected by anti-GST most likely were GST-
Elm Ip degradation products cleaved at the carboxy terminus because anti-GST 
recognized residues at the amino terminus ; this was similar to the protein 
degradation pattern detected in extracts from ELMl-XP-infected insect cells (Fig. 
4). In extract from control Y690[pEGST], the 29 kD GST protein was detected 
with anti-GST (data not shown). Using anti-Elmlp in immunoblot analysis, a 97 
kD protein also was detected in extract from strain Y690[pCK36], but a protein 
migrating near 70 kD, corresponding to the size of Elmlp purified from insect cells, 
could not be detected in strain Y690[pCK35], even when the immunoblot was 
overexposed (Fig. 5B). Thus, Elmlp was detectable as a 97 kD protein when GST 
was placed at the amino terminus with anti-GST and anti-Elmlp, but Elmlp 
alone as not present in yeast cell lysates. 
Because GST-Elm Ip was detectable, the protein was purified via binding to 
glutathione agarose as described in the Materials and Methods. Yeast cell lysates 
were incubated with glutathione agarose followed with washes and the proteins 
attached to the agarose was subjected to immunoblot analysis. After purification, 
a 97 kD protein was detected with both anti-GST and anti-Elmlp specifically in 
galactose-induced cells from strain Y690[pCK36] expressing GAL::GST-ELM1 
(Fig. 5C). 
To verify that Elmlp indeed was the protein purified on glutathione 
agarose, pCK36, which contained GAL::GST-ELM1, was modified by removing 
part of the carboxy terminus. Constructs pCK36-Tl and pCK36-T2 were 
identical to pCK36 except that 42 amino acids and 100 amino acids were removed 
from the carboxy terminus of Elmlp, respectively (Fig. 2, Table 2); hybrid genes 
from pCK36-Tl and pCK36-T2 were termed GAL::GST-ELM1-T1 and GAL::GST-
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ELMl-112, respectively, and hybrid proteins expressed were termed GST-Elmlp-
T1 and GST-Elmlp-T2, respectively. To establish that these truncated hybrid 
proteins were functional, pCK36-Tl and pCK36-T2 were transformed into strain 
aWAelmlH and the ability to complement the constitutive pseudohyphal 
phenotype of the elml strain was examined. Strains aWAeZm2H[pCK36-Tl] and 
aWAeZm2if[pCK36-T2] grew in the yeast-form in galactose (Fig. 3B-4) and as 
pseudohyphae in glucose (data not shown), which was identical to the morphology 
of aWAeZmiH[pCK36] expressing GAL::GST-ELM1. Thus, these tnmcation 
proteins were fimctional, indicating that sequences in the carboxy terminus were 
not required for growth in the yeast-Uke morphology. 
To determine if removal of sequences from the 3' end of the GST-ELMl 
coding region corresponded to a decrease in size of the truncation protein, total 
lysates from strains Y690[pCK36], Y690[pCK36-Tl], Y690[pCK36-T2], and 
Y690[pEGST] were analyzed by immimoblot analysis with anti-GST (Fig. 6A). 
Hybrid proteins coded by GAL::GST-ELM1-T1 and GAL::GST-ELM1-T2 were 
smaller in size than GST-Elmlp (Fig. 6A). Specifically, GST-Elmlp-Tl coded by 
pCK36-Tl was 1-2 kD smaller on the immunoblot than GST-Elmlp. The 
decrease in size seemingly was less than the predicted decrease in molectdar 
weight (4 kD, based on removal of 42 amino acids) but in making the truncation, 
the termination codon was removed; therefore, additional residues probably were 
translated until a stop codon was reached. The fusion protein GST-Elmlp-T2 
coded by pCK36-T2 was approximately 11 kD smaller in molecular weight, based 
on removal of 100 amino acids, than GST-Elmlp; the protein identified on the 
immunoblot was the same size. Protein extracts from strains Y690[pEGST], 
Y690[pCK36], and Y690[pCK36-T2] grown in the presence of galactose were 
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Figure 6. GST-Elmlp specifically is purified on glutathione agarose. 
Strains Y690[pEGST] expressing GST, Y690[pCK36] expressing GST-Elmlp, 
Y690[pCK36-Tl] expressing GST-Elmlp-Tl, and Y690[pCK36-T2] expressing 
GST-Elm lpT2 were grown in raffinose to a density of 1 x lO'^ cells/ml and then 
induced by the addition of galactose to 4% (v/v). Total cell lysates were prepared 
and purified on glutathione agarose; and anti-GST and anti-ELmlp were used for 
immvm.oblot analysis. (A) Proteins of 97 kD, 95 kD, and 86 kD were detected by 
anti-GST in total lysates from galactose-induced strains Y690[pCK36], 
Y690[pCK36-Tl], and Y690[pCK36-T2], respectively. (B) GST-ELMl fusion 
proteins from galactose-induced strain Y690[pCK36] and Y690[pCK36-T2] were 
purified ^vith glutathione agarose as described in the Materials and Methods. 
Results from immunoblot analysis with anti-Elmlp showed that proteins with the 
same decrease in molecular weight were purified fi'om total lysate. 
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purified with glutathione agarose and analyzed with anti Elmlp on an 
immunoblot. GST-Elmlp-T2, coded by pCK36-T2 and purified on glutathione 
agarose, was 11 kD smaller than GST-Elmlp (Fig. 6B), this protein also was 
identical in molecular weight to the proteins detected in total extract before 
piirification (Fig. 6A). Thus, anti-Elmlp is specific for Elmlp and the protein 
purified on glutathione agarose specifically is GST-Elmlp based on results of 
immxinoblot analyses of GST-Elmlp truncation proteins from yeast. 
Elmlp is a serine/threonine protein kinase. Because Elmlp was 
ptxrified from yeast and insect cells, kinase activity of Elmlp was determined by 
by transfer of [y-^Sp] from ATP to phosphoacceptors and Elmlp. With GST-
Elmlp fusion proteins purified from yeast cells, autophosphorylation was tested 
by incubation of purified GST-ELMl hybrid proteins and control GST on 
glutathione beads with [Y-32p]ATP (Fig. 7D). Autophosphorylation of Elmlp 
occurred specifically in galactose-induced cells. Elmlp degradation products 
(proteins of the same size were recognized by anti-Elmlp and anti-GST.) were 
phosphorylated, indicating that potential autophosphorylation sites were present 
in the kinase domain or amino terminus. In addition, general protein kinase 
substrates histone HI (Fig. 7A), casein (Fig. 7B), and MBP (Fig. 7C) were 
phosphorylated by Elmlp specifically in galactose-induced cells. Elmlp kinase 
activity for casein seemingly was lower than activity for the other substrates 
when the intensity of Elmlp autophosphorylation was compared to the intesity of 
phosphoacceptor phosphorylation on the same gel. Protein kinase activity was 
not detectable in control reactions with GST protein. Thus, kinase activity 
correlated with the presence of GST-ELMl fusion proteins. 
Figure 7. Purified GST-ELMl hybrid proteins phosphorylated phosphoacceptors. GST-ELMl Vision 
proteins were isolated from strains Y690[pCK36], Y690[pCK36-Tl], and Y690[pCK36-T2] grown in raffinose or 
galactose and purified on glutathione agarose. Strain Y690[pEGST] was included as a control. The beads 
containing Elmlp fusion protein or the control GST were incubated with various protein kinase substrates as 
described in the Materials and Methods. (A) histone HI (4 mg/ml); (B) casein (1 mg/ml); (C) myelin basic 
protein; (D) autophosphorylation. 
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In addition, to determine if Elmlp from insect cells was catalytically active, 
phosphorylation assays similar to those described previously were performed. 
After elution from the Ni2+ agarose colimm, fractions 8,9, and 10, which 
contained the most full-length Elmlp from ELMl-XP-infected insect cells, were 
incubated with [y-^^PJATP alone or with [y-32p]ATP and general 
phosphoacceptors histone HI, histone H2b, MBP, and phosphorylase b (Fig. 4, 8) 
As a control, fractions 6, 8, and 10 from the WTV-infected cells were tested 
identically. Autophosphorylation of Elmlp occurred specifically in protein 
fractions purified from ELMl-XP-infected cells (Fig. 8A). In addition, Elmlp 
phosphorylated histone HI (Fig. 4), MBP (data not shown), and histone H2b (Fig. 
8B). Phosphorylation of phosphorylase b was not detected when incubated with 
Elmlp (Fig. 8C), indicating that Elmlp has substrate specificity. Phoshorylation 
activity was not detected in protein lysates from control WTV-infected insect 
cells. Consequently, kinase activity correlated with the presence of Elmlp in 
insect cell lysate. 
To confirm that Elmlp was a serine/threonine protein kinase, 
autophosphorylation assays were further analyzed by phosphoamino acid 
analysis (4). After autophosphorylation assays with GST-Elmlp purified on 
glutathione beads and Elmlp purified from insect cells, reactions were acid 
hydi olyzed and separated in two-dimensions. Serine and threonine residues were 
phosphorylated specifically in conditions where Elmlp was present in yeast and 
insect cells (Fig. 9). Phosphotyrosine was not detected. GST-Elmlp-Tl and GST-
Elmlp-T2 had identical phosphoamino acid patterns, indicating that 
autophosphorylation sites were located in regions of the protein kinase domain and 
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Figure 8. Purified Elmlp from insect cells phosphorylated protein kinase 
substrates. 3 jil of fractions 8, 9, and 10, enriched in Elmlp after elution firom the 
Ni+2 agarose coltunn (Fig. 4C), were incubated in kinase assays as described in 
the Materials and Methods. In addition, corresponding fractions 6,8, and 10 (Fig. 
4C) from WTV-infected insect cells were controls. (A) Autophosphorylation; (B) 
histone H2b (1 mg/ml); (C) phosphorylase b (1 mg/ml). 
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Insect Cells Yeast Cells 
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pEGST 
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Figure 9. Elmlp autophosphorylates on serine and threonine. 
Phosphoamino acid analysis was as described in the Materials and Methods using 
autophosphorylation reactions with Elmlp from insect cells or G&V-ELMl hybrid 
proteins on glutathione agarose from yeast cells. Protein piorified from WTV-
infected insect cells and Y690[pEGST] were controls. The locations of standards 
phosphoserine (pS), phosphothreonine (pT), and phosphotyrosine (pY) were 
indicated. 
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amino terminus. Using phosphoamino acid analysis, Elmlp specificiaUy 
autophosphorylates on serine and threonine residues. 
To further ascertain that the kinase activity was specific to Elmlp and not 
to some protein that co-purifies with Elmlp, pCK77 (Fig 2, Table 2) was 
constructed; pCK77 was identical to pCK36 containing GAL::GST-ELM1, except 
that residue Lys^^ in Elmlp was changed to ArgH^, The fusion protein coded 
by pCK77 was termed GST-Elmlp^S^l'^. The lysine residue in Elmlp 
corresponded to a lysine residue that has been conserved in all protein kinases and 
was essential for catalytic activity of cAMP-dependent protein kinase (12,13,17). 
To determine if catalytic activity was necessary for Elmlp function in vivo, strain 
aWAelmlH[pCK17], which expressed GST-Elmlp^sH^^ ^^as grown in media in 
which glucose or galactose was the carbon source. Strain aWAeZmi/?[pCK77] 
grew constitutively as pseudoh3T)hae regardless of the carbon source (Fig. 3B-5,6) 
(3). Thus, catalytic activity of Elmlp in vivo is requisite for growth in the yeast­
like form. 
To confirm that the loss in catalytic activity in vivo also occurred in vitro, 
GST-Elmlp^Sll"^ from strain Y690[pCK77] was purified and tested in kinase 
assays. In autophosphorylation assays, only GST-Elmlp autophosphorylated in 
the presence of [Y-32p]ATP (Fig. lOA). In addition, GST-Elm Ip^S'H'^ was not 
able to phosphoiylate histone HI (Fig. lOB) or MBP (Fig. IOC) in comparison to 
the catalytic activity of GST-Elmlp. Thus, Elmlp was a serine/threonine protein 
kinase in vitro and in vivo. 
Elmlp phosphorylates yeast proteins in vitro. Because Elmlp is a 
ser/thr protein kinase and does not show significant homology to other protein 
kinases, the next task was to determine substrates and effectors of the protein 
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Figure 10. GST-Elmlp^sH'^ does not have kinase activity. Strains 
Y690[CK36], y690[CK77], and Y690[pEGST] were grown in the presence of 
galactose and GST-ELMl hybrid proteins were purified on glutathione agarose. 
The beads containing GST-ELMl hybrid proteins or the control GST were 
incubated with various protein kinase substrates as described in the Materials 
and Methods. (A) Autophosphorylation assays; (B) histone HI; (C) MBP. 
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kinase so as to place Elmlp in a possible pathway that controls cellular 
morphology. As a first step towards identifying Elmlp susbstrates in vivo, the 
possible substrates of Elmlp were examined in yeast cell protein lysates in vitro. 
Total yeast protein extract was prepared from an ELMl null strain and gently 
heated to inactivate endogenous protein kinases; endogenous phosphorylation 
activiiy was not detectable in the presence of [Y-32p]ATP (Fig. 11, left panel). 
This heat-treated protein extract was incubated with piarified Elmlp from ELMl-
XP-infected insect cells or the control fraction in the presence of [y-^^pjATP (Fig. 
11, right panel). If Elmlp or the control fi'action were gently heated, kinase 
activity was not detectable. Residts from incubations with active insect cell 
lysates showed that an endogenous kinase, present in both firactions purified firom 
WTV- and ELMl-XP-infected insect cells, phosphorylated two proteins near 60 kD 
and 35 kD. However, at least six additional phosphorylated proteins, at molecular 
weights of 68 kD, 43 kD and between 18-30 kD, were detected specifically in 
reactions in which lysate fi'om ELMl-XP-infected insect cells was incubated with 
yeast cell lysate; the 68 kD phosphorylated protein most likely was Elmlp. 
Preliminary results indicated that specific proteins firom yeast cell lysates serve 
as general phosphoacceptors when incubated with Elmlp from insect cells. 
Discussion 
Elmlp functions downstream of the MAP kinase cascade in the 
pheromone response pathway. Genetic evidence indicated that J5LM2 
functions dovmstream of STE7 anA. STEll because deletion of STE7 and STEll, 
which prevents a vdld type yeast strain fi'om grovwng as pseudohyphae on low 
ammonia media (21), did not prevent an elml mutant fi:om growing constitutively 
at pseudohyphae. Alternatively, ELMl could function in a parallel pathway. 
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Figure 11. Elmlp phosphoiylated yeast proteins in vitro. Total protein 
from an elml strain was prepared using the glass bead lysis procedure. Elmlp 
protein was purified from insect cells as described in the Materials and Methods. 
As a control, corresponding fraction from WTV-infected insect cells was included. 
Yeast proteins were gently heated at 70°C for 10 min. to inactivate endogenous 
kinases and used in kinase assays at 6 mg/ml; aliquots of Elmlp and the control 
also were heat-inactivated. (Left panel) phosphorylation assay with heat-
inactivated yeast proteins; (Right panel) phosphorylation assay with heat-
inactivated yeast proteins and Elmlp or control, active and heat-inactivated. 
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Elmlp is a novel serine/threomne protein kinase. Because genetic 
data suggested that protein phosphorylation regulated pseudohyphal growth, 
Elmlp was expressed and purified fi:om insect and yeast cells for biochemical 
analysis in vitro. Purified Elmlp phosphorylated general protein kinase 
substrates and autophosphorylated on serine and threonine residues. 
Phosphorylation was specific because phosphorylase b was not phosphorylated 
and casein was phosphorylated to a lesser extent than histone HI and MBP. 
Catalytic activity was lost in vitro when Lys^l^^ which was conserved in all 
protein kinases and essential for kinase activity in cAPK (12,13,17), was 
changed to Arg^"^; this catal3^ic activity also was essential for growth in the 
yeast-like morphology in vivo. Thus, sequence homology showing that ELMl 
codes for a serine/threonine protein kinase has been confirmed in vitro and in vivo. 
Elmlp protein stability. That Elmlp seemingly was not stable and 
levels of the protein were kept very low in the cell was supported by the following 
observations. First, the ELMl mENA was only detected after overexposure of the 
Northern blot. In addition, Elmlp was not detectable when imder control of its 
own promoter or of the strong, inducible GALl promoter, even though anti-Elmlp 
and anti-HA were adequate for detecting Elmlp. In the case where Elmlp was 
expressed under control of the GALl promoter, the ELMl transcript was easily 
detectable in total RNA and levels of the protein were adequate to restore the 
constitutive pseudohyphal phenotype of an elml mutant to the yeast-like 
phenotype. Finally, Elmlp was only detectable when a GST fusion was placed at 
the amino terminus. Thus, although indirect, evidence suggests that the 
expression of Elmlp is tightly regulated in the cell. 
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Because the presence of extra sequences at the amino terminus served to 
stabilize Elmlp, sequences in the regions flanking the kinase domains were 
analyzed. Elmlp was a very hydrophilic protein as shown on the Kyte-Doolittle 
hydropathy plot (Fig. 2). Analysis of the amino and carboxy regions flanking the 
kinase domain (Fig. 2) revealed potential PEST regions (28) that were located 
from amino acids 24-51 (PEST score 10.6) and 503-533 (PEST score 1.8). PEST 
regions are stretches rich in proline (P), glutamate (E), serine (S), and threonine 
(T) that may serve as signal for rapid intracellular proteolysis (26, 28). Examples 
of other proteins with PEST motifs that are tightly regulated in the cell cycle are 
yeast G1 cyclins (11, 36),and yeast subiuiit/substrate inhibitor of Cdc28p 
(S/Ci )(25). The presence of PEST regions in Elmlp may be indicative of cell cycle 
specific regulation. Removal of the PEST regions from the carbosy terminus did 
not affect detection of Elmlp; perhaps removal of the amino terminal PEST 
sequence may lead to stabilization of the protein. 
Physiological role of Elmlp. The regulation of Elmlp and the 
physiological substrates of Elmlp have yet to be determined. From sequence 
analysis, Elmlp was not placed in a specific protein kinase family, such as the 
MAP kinase family or PKC family. Possible substrates of Elmlp were identified in 
vitro. Candidates were approximately 43 kD and 18-30 kD in molecular weight. 
Further experiments to identify physiological substrates may provide insight in 
pseudohyphal growth regulation. Genetic identification of suppressors of Elmlp 
will identify targets downstream of Elmlp. Two-hybrid analysis will reveal 
proteins that Elmlp interacts with in vivo. Morphological analysis of cells 
overexpressing GST-ELMl hybrid proteins may provide further clues as to how 
Elmlp regulates pseudohyphal growth. A combination of these techniques with 
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biochemical experiments will result in the identification of physiological substrates 
of the serine/threonine protein kinase Elmlp. 
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CHAPTER 3. MORPHOLOGIC ANALYSES OF Elmlp 
OVEREXPRESSION IN SACCHAROMYCES CEREVISIAE 
A paper to be submitted to the Joiamal of Cell Biology 
Carla M. Koehler and Alan M. Myers 
Abstract 
The serine/threonine protein kinase Elmlp controls dimorphism in the 
budding yeast Saccharomyces cerevisiae. Deletion of ELMl resulted in a 
constitutive pseudohyphal phenotype (3). In constrast, overexpression of Elmlp 
as a fusion protein with glutathione S-transferase (GST) at the amino terminus 
(termed GST-Elmlp) produced cells with a very elongated bud morphology similar 
to that of cells with hyperactive Cdc28/Cln complexes or reduced Cdc28/Clb 
activity. Other characteristics of this phenotype were that cells were cytokinesis 
defective, uninucleate, and nuclei were located at the neck between the mother 
and bud. This phenotype was dependent upon the presence of sequences in the 43 
amino acids at the carbo:^ terminus of Elmlp and independent of Elmlp 
catalytic activity. In additional experiments, cells overexpressing GST-Elmlp and 
Phdlp, a dominant pseudohyphal determinant, had a phenotype identical to the 
phenotype observed with GST-Elmlp overexpression rather than the 
pseudohyphal phenotype characteristic of Phdlp overexpression. In epistasis 
experiments of GST-Elmlp overexpression in other constitutive elm mutants (2, 
3), the GST-Elmlp overexpression phenotype of very long buds was dominant to 
pseudohyphal growth. These resTilts suggested that Elmlp may play a role in cell 
cycle control or may be activated at a particular time in the cell cycle by Cdc28p. 
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Introduction 
Saccharomyces cerevisiae is dimorphic; it can grow in the yeast form or the 
pseudohyphal form (3,5,12,15). The yeast form is characterized by a unicellular 
oval shape. In pseudohyphae, the cells have an elongated shape and stay 
attached to each other presumably by their cell walls. The budding pattern is 
unipolar in which daughter cells bud and rebud at the pole opposite their birth pole. 
This resulting change produces a filamentous, branched structure growing away 
fi'om the center of the colony. In addition, cells are able to penetrate the agar 
media. The switch in morphology fi:om yeast form to pseudohyphal form can be 
induced by nitrogen starvation in the presence of glucose (12). 
Switching between yeast-like growth and pseudohyphal growth requires 
modification in cell cycle progression. In the yeast form, Start is at GIM, 
whereas in pseudohyphal cells, budding is synchronized and Start is at G2/M (20). 
These changes require modification of cell cycle progression. Cellular morphology 
is affected by Cdc28p-cyclin complexes. Cdc28p complexes with the G1 cyclins 
(CLNs) trigger polarization of cortical actin and secretion, while activation of 
Cdc28p by the G2 cyclins (CLBs) causes depolarization of the cortical actin 
cytoskeleton and secretory apparatus (22), 
In general, the cell cycle is controlled by the sequential activation of a series 
of eychn-dependent kinase complexes, which regulate the various checkpoints 
controlhng DNA replication, spindle pole body duplication, and budding. In the 
yeast form, the major G1 phase checkpoint of the cell cycle is at Start and is 
regulated by the G1 cyclins CLN1,2,3 (17,21,25,30). Cdc28-Cln formation is 
regulated by Cln3p (33). In addition, Cdc28p associates with the products of six 
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B-type cyclins CLBl-6. Clblp and Clb2p appear during G2, whereas ClbSp and 
Clb4p appear at the end of S (9,14,29). Mutants lacking clhl-4 enter S with 
normal kinetics, but fail to form bipolar spindles (1). ClbSp and Clb6p appear in 
late G1 and are important for initiation of S (8,34). 
Three other gene products required for cells to enter S are CDC4, CDC34, 
and CDC53. CDC34 codes for a ubiquitin-conjugating enzyme (13), and CBC4 
codes for a protein that contains copies of a motif foimd in fi-transducins (38). The 
CDC4 gene product is required for CDC34p to function (13), Mutants defective in 
these genes duplicate spindle pole bodies and continue to form elongated buds but 
fail to enter S phase at the restrictive temperature. In addition sextuple clbl-6 
mutants or cells overexpressing p40®^^-^ show a similar phenotype (26, 33). 
Siclp acctmiulates in G1 and inhibits Cdc28p/Clb5p complex activity; it does not 
affect the activity of the Cdc28/Cln complexes (33). Once a cell has passed Start, 
Siclp is degraded by a ubiquitin-dependent proteolysis pathway involving Cdc34p 
and no longer inhibits Cdc28p/Clb5p complex and thus allows entry into S. Cell 
cycle progression is regulated not only by the appearance of cyclin proteins at 
particular stages in the cell cycle, but also by programmed destruction of cyclin-
dependent kinase inhibitors. 
Previously, 14 elm mutants that constitutively displayed pseudohyphal 
growth characteristics were identified (2,3); these mutants have an elongated cell 
morphology and are able to penetrate the agar. Some of these gene products may 
affect cell cycle progression or perhaps be activated in a cell cycle dependent 
manner. ELMl, which codes for a serine/threonine protein kinase, may be one 
candidate because the transcript and protein are expressed at extremely low 
levels in the cell and the protein contains PEST sequences (Chapter 2), which are 
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associated with proteolysis. Examples of genes coding proteins with PEST 
sequences are CLN1,2,3 and SICl (17,26, 36). The current study was 
undertaken to determine if Elmlp overexpression affected cellular morphology or 
cell cycle progression. Expression of GST-Elmlp resulted in a phenotype 
consistent with inhibition of Cdc28 association with the CLB gene products, in 
which cells arrested in G1 and contained multiple buds that were up to five times 
longer than an oval yeast cell. This phenotype was not suppressed when Elmlp 
was expressed in other elm mutants or cells overexpressing Phdlp, a dominant 
pseudohyphal determinant (11). These results suggest that Elmlp may be 
involved in cell Qrcle progression or is activated by association with Cdc28/Cln 
complexes. 
Materials and Methods 
Media and genetic methods. The following media were used; YPD (1% 
yeast extract, 2% peptone, 2% glucose); SD (2% glucose, 0.7% yeast nitrogen base 
without amino acids, supplemented as required with leucine, tryptophan, lysine, 
uracil, histidine, methionine, and adenine at 20 |Xg/ml each); SG (2% galactose, 
0.7% yeast nitrogen base without amino acids, supplemented as required with 
auxotrophy requirements listed above); SR (2% raffinose, 0.7% yeast nitrogen 
base without amino acids, supplemented as required with auxotrophy 
reqioirements Usted above). Solid media for yeast contained 2% agar. Yeast 
strains were transformed using the LiCl procedure (31,32). 
Strains and alleles. S. cerevisiae strains used in this study are described 
in Table 1. Yeast strains were cultxored at 30®C. Alleles used in this study are 
described in Chapter 2 with the exception of those described below. pYEPPHDl 
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and pRSPHDl alleles (provided by Nicholas Edgington) contained a PHDl 
genomic fragment in 2|i vector YEpSSl and centromeric vector pRS315, 
respectively. Allele pLEUGAL4 was constructed by removing a 3.5 kb BarriHl 
fragment containing ADHlp-GAL4 from pMA210 (23) and inserting into the 
multiple cloning region of YEp351. 
For overexpression studies, ELMl gene fusions pCK35 expressing Elmlp, 
pCK36 expressing GST-Elmlp, pCK36-Tl expressing GST-Elmlp-Tl, pCK36-T2 
expressing GST-Elmlp-T2, pCK77 expressing GST-Elmlp^sH''' with 
pLEUGAL4 or pHISGAL4 were co-transformed into D273-10B/A6, Y690, and 
NW. As controls, similar transformations included pBMlSO and pEGST with 
pLEUGAL4 or pHISGAL4. Delml, the constitutive pseudohyphal mutant, was 
co-transformed with pEGST and pLEUGAL4 for comparisons of phenotypes 
caused by overexpression and loss of expression. 
For overexpression experiments of Phdlp and GST-Elmlp, the following 
combinations of alleles were transformed into strain D273-10B/A5: pCK36, 
pHISGAL4, and pYEPPHDl; pCK36, pHISGAL4, and pRSPHDl; pCK36, 
pHISGAL4, and pRS315; pEGST, pHISGAL4, and pYEPPHDl; pEGST, 
pHISGAL4, and pRSPHDl; pEGST, pHISGAL4, and pRS315. 
For epistasis experiments to test the effects of ELMl overexpression in the 
other elm mutants, pCK36 was transformed into the DeZm mutant collection 
listed in Table 1. In addition, both pCK36 and pLEUGAL4 were co-transformed 
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Table 1. S. cerevisiae strains. 
Strain Genotj^je Source or derivation 
D273-10B/A1 
D273-10B/A4 
D273-10B/A5 
D273-10B/A6 
Y690 
NW 
Delml 
Helm2 
'Delm2IA. 
DelTn3 
'Delm4IK 
Delm5 
DeZmS 
Helm? 
'Delm7IA. 
T>elm8 
T)elm9 
DelmlO 
Delmll 
Delml2 
DelmlS 
Delml4 
Delml4/A 
MATa. met6 
MATa ura3 
MATa ura3leu2his3 
MATa uraS leu2 
M. Blacketer 
A Tzagolofif 
N. Edgington 
M. Blacketer 
MATa!a leu21leu2 ura31uraS R. Deschenes 
his3lhis3 [pHIS3GAL4] 
MATa la leu21 leu2 ura3 / ura3 J. Sturges 
his31 his3 trpl / trpl 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
MATa ura3 
leu2 metS elml-1 
met6 elm2-l 
leu2 metS elm2-l 
metS elm3 -1 
leu2 met6 elmd-l 
metS elm5-l 
metS elmS-l 
metG elm7-l 
leu2 metG elm7-l 
metS elm8-l 
metS elm9-l 
metS elmlO-1 
metG elmll-1 
metG elml2-l 
metG elml3-l 
metG elml4-l 
leu2 mjetG elml4-l 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
M. Blacketer 
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into 'Delm2IA, Tyelm4IK, "DelmJIK, and Tielml4IK. pEGST and pEGST with 
pLEUGAL4 were transformed as controls, respectively. 
Overexpression of Elmlp. Conditions for induction of GST-Elmlp are as 
follows. For liquid cultures, strains were grown to a density of 5 x 10® cells/ml in 
SR followed by galactose addition to a final concentration of 4% (v/v). Cells were 
grown for another 6-24 hours. Uninduced controls were grown in SR. For cultures 
grown on plates, cells were patched on SD and SR and examined after 16-24 
hours. 
Morphological analyses. Colony morphology was examined by using an 
inverted microscope to observe the cells through the agar. Cells were obtained 
fi:om liquid cultures or by suspending cells from an agar dish in a drop of 1.2 M 
sorbitol or distilled water and observed at higher magnification by phase-contrast 
or Nomarski optics. Cytokinesis was monitored as described by Hartwell (18). 
Procedures for formaldehyde fixation and removal of the cell wall by treatment 
with Glustdase were described in Pringle et al. (28). Nuclei were visualized xising 
4',6-diamino-2-phenylindole (DAPI, Sigma Chemical Co., St. Louis, MO) (28). 
Results 
Overexpression of GST-Elmlp affects cell morphology. Because the 
elml mutant grew constitutively as pseudohyphae comprised of somewhat 
elongated cells, cell morphology was investigated when Elmlp was overexpressed. 
Strain D273-10B/A6 was co-transformed with pLEUGAL4 and pCK35, pBM150, 
pCK36, pCK36-Tl, pCK36-T2, pCK77, or pEGST. The presence of pLEUGAL4 
insured that adequate levels of the transcriptional activator GAL4 were present 
imder induction conditions. In pCK35, native Elmlp was expressed under control 
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of the GALl promoter. In pCK36 and truncation constructs pCK36-Tl and 
pCK36-T2, the fusion protein GST-Elmlp was expressed from GAL::GST-ELM1 
gene fusions. GST-Elmlp-Tl from pCK36-Tl and GST-Elml-T2 from pCK36-T2 
were identical to GST-Elmlp except 43 amino acids and 100 amino acids were 
removed from the carboxy terminus, respectively. pCK77 was identical to pCK36 
except that in GST-Elmlp, Lys^'^, which is essential for cataljrtic activity 
(Chapter 2), has been changed to ArgH"^. Strain Belml, which is isogenic to 
D273-10B/A6 except for an elml mutation, was co-transformed with pLEUGAL4 
and pEGST, which expresses GST protein, as a control to demonstrate any 
phenotypic differences between an eZm2 mutant and Elmlp overexpression. 
Results from Chapter 2 showed that Elmlp was detected only when GST was 
fused to the amino terminus; Elmlp from GAL::ELM1 was not detectable in 
immunoblot analysis. Thus, the effects of Elmlp overexpression were determined 
in conditions where Elmlp was and was not detectable. 
To observe phenotypic differences, liquid cultures grown in galactose and 
raffinose were compared 12-36 hours later. The phenotj^e of 
DeZm2[pEGST][pLEUGAL4] was characterized as constitutively pseudohj^ihal 
(3); in liquid, the cells were somewhat elongated, regardless of the carbon source 
(Fig. lA). Themorphology of D273-10B/A6[pCK36][pLEUGAL4] expressing 
GST-Elmlp and D273-10B/A6[pCK77][pLEUGAL4] expressing GST-
Elmlp^Sll^ vv^as quite different in galactose-induced cells (Fig. ID and IF, 
respectively) in comparison to D273-10B/A6[pEGST][pLEUGAL4] expressing 
GST protein (Fig. IB) and the Tielml mutant (Fig. lA). Between 25% and 50% of 
the cells expressing GST-Elmlp or GST-Elmlp^Sll"^ in galactose cultures were 
highly elongated, often 5-6 times longer than a normal yeast cell. After prolonged 
Figure 1. GST-Elmlp overexpression affects cellular morphology. Cells 
were grown as liquid cvdtures in SR until a density of 5 x 10® cells/ml followed 
by addition of galactose to 4% (v/v). Morphology of individual cells in galactose 
was examined 12-36 hours later with NomarsM optics. (A) 
De/7n2[pEGST][pLEUGAL4], expressing GST; (B) D273-10B/A6[pEGST] 
[pLEUGAL4], expressing GST; (C) D273-10B/A6[pCK35][pLEUGAL4], 
expressing Elmlp; (D) D273-10B/A6[pCK36][pLEUGAL4], expressing GST-
Elmlp; (E) D273-10B/A6[pCK36-Tl][pLEUGAL4], expressing GST-Elmlp-
Tl; (F) D273-10B/A6[pCK77][pLEUGAL4], expressing GST-ElmlpArgll7. 
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periods (16 hr) of induction, phenotypes in which mother cells often had two or 
more elongated buds or which consisted of very long tubular buds with periodic 
constrictions were present. The elongated phenotype of GST-Elmlp 
overexpression resembled the terminal phenotype of cdc4, cdc34, and cdc53 
mutants, which arrest in G1 with multiple buds (13, 38), and a phenotype of SICl 
overexpression (26). This aberrant cell morphology was dependent upon the 
presence of galactose as cidtures grown in glucose were oval-shaped like cells in 
Fig. IB (data not shown). In contrast, strain D273-10B/A6[pCK35][pLEUGAL4], 
which contained gene fusion GAL::ELM1, and D273-10B/A6[pCK36-
Tl][pLEUGAL4] and D273-10B/A6[pCK36-T2][pLEUGAL4], which expressed 
carboxy terminal GST-Elmlp tnmcations, did not possess the identical highly 
elongated phenotype but rather looked like wild-type cells (Fig. IC and IE). The 
phenotype was independent of the strain as phenotypes observed with gene 
constructs in strains NW and Y690 were identical to results from strain 
D273010B/A6. Thus, the aberrant morphology characterized by tubular cells 
correlated to the presence of full-length GST-Elmlp and was independent of (JST-
Elmlp kinase activity. In addition, DeZml[pEGST][pLEUGAL4] was able to 
penetrate agar media, but strains overexpressing full-length GST-Elmlp did not 
possess this characteristic. 
Because the phenotype of GST-Elmlp overexpression was suggestive of a 
block in the cell cycle, the nuclei in strains expressing GST-Elmlp and (JST-
Elmlp^Sll'^ were observed by staining the cells with the DNA specific dye 
DAPI. Cells were grown in raffinose to early-log phase, switched to galactose and 
after 12 hours, stained with DAPI. In strain DeZmi[pEGST][pLEUGAL4], 
expressing GST, nuclear division was normal (Fig. 2A); each cell contained one 
Figure 2. Nuclear division is defective in cells overe3q)ressing full-length 
GST-Elmlp. Cells were grown to 3 x 10® cells/ml in SR, induced by addition of 
galactose to 4% (v/v), and grown for 12 hours followed by staining with the 
DNA-specific stain DAPI (28). Panels on the left were visualized tising 
Nomarski optics. Panels on the right were the same field of cells, visualized 
using fluorescence. Magnification is lOOOX. (A) DeZm2[pEGST][pLEUGAIi4], 
expressing GST; (B) D273-10B/A6[pEGST][pLEUGAL4], expressing GST; (C) 
D273-10B/A6[pCK36][pLEUGAL4], expressing GST-Elmlp; (D) D273-
10B/A6[pCK77][pLEUGAL4], expressing GST-ElmlpArgll7. 
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nuclei (because the cells are attached, some of the nuclei are out of the plane of 
focus). In strain D273-10B/A6[pCK36][pLEUGAL4] expressing GST-Elmlp and 
D273-10B/A6[pCK77][pLEUGAL4] expressing GST-ElmlpArgll7 (pig. 2C and 
2D), galactose-induced cells were uninucleate and the nuclei generally were located 
in the neck between the mother and bud, unlike control strain D273-
10B/A6[pEGST][pLEUGAL4] expressing GST (Fig. 2B). Nuclei examined in cells 
expressing Elmlp, GST-Elmlp-Tl or GST-Elmlp-T2 were like that of the control 
in Fig. 2B (data not shown). Nuclear division perturbations associated with full-
length Elmlp overexpression are also characteristic of cdc4 (19) and SICl 
overexpression (26). Thus, the morphology characteristic of fiall-length GST-
Elmlp overexpression correlated with defective nuclear division. 
The ability of the cells overexpressing full-length Elmlp to complete 
cytokinesis was assayed. Cells were grown in raffinose or galactose, followed by 
cell wall removal and light sonication (18,28). In liquid cultures, strain 
DeZm2[pEGST][pLEUGAL4] grew in clumps and the cells remained attached. 
After removal of the cell wall, single cells, with or without a single bud, were 
dispersed indicating these cells are not defective in cytokinesis (Fig. 3A). Strain 
D273-10B/A6[pCK35][pLEUGAL4], in which the ELMl transcript was present 
but Elmlp was not detectable, was not defective in cytokinesis and identical to 
the control D273-10B/A6[pEGST][pLEUGAL4] (Fig. 3B, 3G, and 3H). In 
galactose-induced cultures, D273-10B/A6[pCK36][pLEUGAL4] and D273-
10B/A6[pCK77][pLEUGAL4], in which full-length GST-Elmlp was expressed, 
were defective in cytokinesis; cells remained attached despite loss of the cell wall 
(Fig. 3D and 3F). The defect in cytokinesis also was dependent on cells being 
grown in the presence of galactose as cells grown in glucose were not defective in 
Figure 3. Cytokinesis is defective in cells overexpressing full-length 
Elmlp. Cells were grown to 3 x 10® cells/ml in SR, induced by addition of 
galactose to 4%, and then grown for 12 hours. Cells were assayed for the 
ability to complete cytokinesis by cell wall removal with Glusulase followed by 
sonication (18, 28). (A) DeZml[pEGST][pLEUGAL4] expressing GST in SG; 
(B) D273-10B/A6[pEGST][pLEUGAL4] in SG; (C) D273-10B/A6[pCK36] 
[pLEUGAL4] expressing GST-Elmlp in SR; (D) D273-10B/A6[pCK36] 
[pLEUGAL4] in SG; (E) D273-10B/A6[pCK77][pLEUGAL4] expressing GST-
ElmlpArgll7 in SR; (F) D273-10B/A6[pCK77][pLEUGAL4] in SG; (G) D273-
10B/A6[pCK35][pLEUGAL4] expressing Elmlp in SR; (H) D273-
10B/A6[pCK35][pLEUGAL4] in SG. 
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cytokinesis and identical to wild-type (Fig. 3C, BE, and SB). Most likely the defect 
in cytokinesis was a consequence of incomplete nuclear division. Strains 
expressing carboxy terminal tnmcations, GST-Elmlp-Tl and GST-Elmlp-T2, 
were not defective in cytokinesis. Consequently, the presence of full-length GST-
Elmlp correlated with a phenolype characterized by highly elongated buds and 
incomplete nuclear division; this phenotype was not dependent on Elmlp kinase 
acitivity. In contrast, an elml mutant grew as pseudohyphae in which cells were 
only shghtly elongated and delayed in cell separation, but nuclear division and 
cytokinesis were normal. 
Effects of overexpression of GST*Elmlp and Phdlp on cellular 
morphology. Because the phenolypes of Elmlp overexpression and elml are 
distinguishable, GST-Elmlp can be used for epistasis studies with other genes 
that affect cell morphology. PHDl was isolated as a suppressor of sell-1 (7); sell-
I is an extragenic suppressor of elml (7). PHDl codes for a putative transcription 
factor, and has been previously identified as an activator of pseudohyphal 
differentiation, causing constitutive pseudohyphal growth on rich media when 
expressed on a 2|i plasmid (11). Deletion oiPHDl did not prevent pseudohyphal 
growth (11) and did not affect the constitutive pseudohyphal phenotype caused by 
elml (7). Elmlp and Phdlp were overexpressed to determine if cellular 
morphology was affected. GST-Elmlp was placed in a strain that expressed 
Phdlp fi:om a high-copy 2^ plasmid or fi:om a low-copy GEN plasmid. As a 
control, GST was expressed in the same combination with Phdlp. Strains were 
patched on SG or SD and visuaUzed 24-36 hours later. In the combination of GST-
Elmlp overexpression from pCK36 with Phdlp overexpression, the Elmlp 
overexpression phenotype was dominant (Fig 4D and 4F), identical to GST-Elmlp 
Figure 4. Effects of overexpression of Elmlp and Phdlp on cellular 
morphology. Strain D273-10B/A5 was transformed with constructs containing 
GAL::GST-ELM1 and PHDl or GAL::G8T and PHDl in addition to a construct 
containing GALA. Cells were patched in SD and SG; after 24-36 hours, cells 
were resuspended in water, and photographed by Nomarski optics. Cells 
pictured here were grown on SG. (A) 1)273-10B/A5[pEGST][pHISGAL4] 
[pRS315] expressing GST and Gal4p with a centromeric empty vector; (B) 
D273-10B/A5[pCK36] [pHISGAL4][pRS315] expressing Phdlp and GST-
Elmlp with a centromeric empty vector; (C) D273-10B/A5[pEGST] 
[pHISGAL4][pYEPPHDl] expressing Phdlp, GST, and Gal4p ; (D) D273-
10B/A5[pCK36][pHISGAL4][pYEPPHDl] expressing Phdlp, GST-Elmlp, and 
Gal4p; (E) D273-10B/A5[pEGST] [pfflSGAL4][pRSPHDl] expressing Phdlp, 
GST, and Gal4p ; (F) D273-10B/A5[pCK36][pHISGAL4][pRSPHDl] 
expressing Phdlp, GST-Elmlp, and Gal4p. 
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overexpression alone (Fig. 4B). Phdlp overexpression only caused slight 
elongation of 5-10% of the cells in the presence of GST (Fig. 4C and 4E). Thus, 
Elmlp overexpression seemingly was dominant to Phdlp overexpression. In 
addition, two-hybrid experiments between Elmlp and Phdlp confirmed that these 
two proteins do not interact in vivo (data not shown). 
Effects of Elmlp overexpression in the other elm mutants on 
cellular morphology. The affect of Elmlp overexpression was tested in other 
Helm backgrounds (Table 1) to determine if GST-Elmlp overexpression 
phenotype was epistatic. Four strains, "061111,21 A, Oelm4lk, 'Delm7IA, and 
HelmMIA., were co-transformed with pLEUGAL4 and pCK36 or control pEGST; 
pLEUGAL4 was included to insure that adequate levels of the transcriptional 
activator GALA were present and to be consistent with Elmlp overexpression 
studies described previously because overexpression studies with Elmlp included 
elevated levels of Gal4p. Strains were patched on SG and SD, and after 24 hours, 
examined microscopically. In all cases, the GST-Elmlp overexpression phenotype 
characterized by highly tubular buds was not suppressed in galactose-induced 
cells (Fig. 5B, 5D, 5F, and 5H) when compared to control strains expressing only 
the GST protein (Fig. 5A, 5C, 5E, and 5G). Interestingly, in DeZm7/A, the tubular, 
multiply budded cells associated with ELmlp overexpression phenotype was 
visible, but the cell remained larger as in DeZ7n7/A[pEGST][pLEUGAL4] (Fig. 5E). 
Thus, overexpression of GST-Elmlp was epistatic to constitutive pseudohyphal 
mutants elm2, elm4, elm7, and elml4. 
Becatase other Helm mutants only were auxotrophic for uracil (Table 1), 
pCK36 expressing GST-Elmlp or control pEGST expressing GST was 
transformed into these mutants; plasmid pLEUGAIj4 was not included. To 
Figure 5. GST-Elmlp overexpression is dominant in mutants elm2, 
elm4, elm7, and elml4. Strains Delm2IA, Delm4tA, Delm7/A, and Delml4/A, 
auxotrophic for uracil and leucine, were co-transformed with pCK36 and 
pLEUGAL4 or pEGST and pLEUGAL4. Cells were patched in SD and SG; 
after 24-36 hours, cells were resuspended in water, and photographed by 
Nomarski optics. Cells pictured here were grown on SG. (A) DeZm2/A[pEGST] 
[pLEUGAL4] expressing GST; (B) DeZ7n2/A[pCK36][pLEUGAL4] expressing 
GST-Elmlp; (C) Delm4IA [pEGST][pLEUGAL4] expressing GST; (D) 
DcZm4/A[pCK36][pLEUGAL4] expressing GST-Elmlp; (E) DeZm7/A[pEGST] 
[pLEUGAL4]expressing GST; (F) DelmJIA [pCK36][pLEUGAL4] expressing 
GST-Elmlp; (G) DeZml4/A[pEGST][pLEUGAL4] expressing GST; (H) 
DcZmi4/A[pCK36][pLEUGAL4] expressing GST-Elmlp. 
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establish that Gal4p was not rate-limiting in GST-Elmlp overexpression, strain 
D273-10B/A4[pCK36], containing endogenous levels of Gal4p, was grown in the 
presence of galactose. Cells exhibited the tubular morphology of GST-Elmlp 
overexpression (Fig. 6B), whereas cells only expressing GST were like wild-type 
(Fig. 6A). Because lack of additional Gal4p did not affect the elongated 
morphology caused by GST-Elmlp overexpression, additional DeZm strains 
transformed with pCK36 or pEGST were patched on SG or SD and examined 24 
hours later. In all cases, the overexpression phenotjrpe of GST-Elmlp was 
dominant in comparison to the constitutive pseudohypal phenotype of Helm 
mutants expressing GST (Fig. 6). In addition, phenoiypes in strains elm2, elm7, 
and elml4 overexpressing GST-Elmlp and Gal4p (Fig. 6) or just GST-Elmlp (Fig. 
5) were identical. Thus, the phenotype of ftill-length GST-Elmlp overexpression, 
characterized by highly tubular buds and defects in nuclear division and 
cytokinesis, was not suppressed in the other elm mutants. 
While GST-Elmlp overexpression was dominant in the elm mutants, other 
interactions were identified. First, Tielml2 transformants expressing GST-Elmlp 
or GST grew on glucose, but when patched on galactose seemingly did not grow 
after one week at 30°C. "DelmG cells expressing GST were much longer on 
galactose than glucose (Fig. 61) (2) and the cells grew quite slowly but the 
pseudohyphal phenotype was present. Cells fi-om DeZw6[pCK36] expressing 
GST-Elmlp were inviable on galactose media (Fig. 6J) and had a terminal 
phenotype characteristic of Elmlp overexpression, which consisted of very long 
tubular buds with periodic constrictions. In addition, strain DeZ/nii [pCK36] grew 
on glucose media, but not on galactose media and exhibited a terminal phenotype 
characteristic of Elmlp overexpression (Fig. 6T); DeZ7nIl[pEGST] grew slowly on 
Figure 6. Elmlp overexpression is dominant in elm mutants. DeZ/ra 
strains auxotrophic for uracil (Table 1) were transformed with pCK36 or 
pEGST. Cells were patched in SD and SG; after 24-36 hoiars, cells were 
resxispended in water, and photographed by Nomarski optics. Strains 
containing pEGST expressed GST and strains containing pCK36 expressed 
GST-Elmlp. Cells pictured here were grown on SG. (A) D273-10B/A[pEGST]; 
(B) D273-10B/A4[pCK36]; (C) DeZm2[pEGST]; (D) DeZm2[pCK36]; (E) 
DeZm3[pEGST]; (F) DeZm3[pCK36]; (G) DeZm5[pEGST]; (H) DeZm5[pCK36]; 
(I) DeZm6[pEGST]; (J) DeZm6[pCK36]; (K) DeZm7[pEGST]; (L) DeZm7[pCK36]; 
(M) DeZmS[pEGST]; (N) DeZmS[pCK36]; (O) DeZm9[pEGST]; (P). 
De/m9[pCK36]; (Q) DeZm20[pEGST]; (R) DeZmI0[pCK36]; (S) 
DeZmi2[pEGST]; (T) DeZmi2[pCK36]; (U) DcZm23[pEGST]; (V) 
DeZm23[pCK36]; (W) DeZmi4[pEGST]; (X) DeZ7Mi4[pCK36]. 
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Figure 6, continued 
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Figure 6, continued 
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Figure 6, continued 
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galactose and had a phenotype of slightly elongated cells (Fig. 6S). Finally, in 
strain DeZm20[pCK36], galactose-induced cells grew extremely long (Fig. 6R) in 
comparison to DeZmiO[pEGST] (Fig. 6Q), but the phenotype was characteristic of 
Elmlp overexpression. Thus, Elmlp overexpression seemingly was dominant in 
the elm mutants, but other genetic interactions also have been identified. 
Discussion 
GST-Elmlp overexpression is distinct from Elmlp loss of function. 
Phenolypes of ELMl deletion and overexpression were distinguishable. The elml 
mutant grew constitutively as pseudohyphae; individual cells were somewhat 
elongated and remained attached and were delayed in cell separation but were not 
defective in cytokinesis. In addition, nuclear division was normal and cells 
penetrated agar medium. In contrast, cells overexpressing Elmlp contained very 
elongated, tubular buds; cells were defective in nuclear division and cjrtokinesis 
and did not penetrate the agar medium. The overexpression phenotype was 
dependent upon the presence of fiall-length GST-Elmlp and was independent of 
Elmlp kinase activity because cells expressing GST-Elmlp^sH'^ possessed the 
phenotype identical to GST-Elmlp overexpression. Strains overexpressing 
Elmlp or the carboxy terminal tnmcations GST-Elmlp-Tl and GST-Elmlp-T2 
had a wild-type phenotype characterized by oval-shaped cells like cells 
overexpressing GST. Perhaps sequences at the carbojqr terminus are responsible 
for the overexpression phenotype and elevated levels of the protein are necessary 
to see the tubular cell morphology, because Elmlp coded by GAL::ELM1 was not 
detectable in immunoblot analysis. Thus, the presence of full-length GST-Elmlp 
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correlated with the overexpression phenotype and with the levels of Elmlp high 
enough to be detected by immunoblot analysis in total cell lysates. 
The phenotype of cells overexpressing ELMl was similar to cells with 
hyperactive Cdc28/Cln complexes or Cdc28/Clb complexes of reduced activity. 
Cells displaying this phenotype were blocked in Gl; spindle pole bodies duplicated 
and bud emergence and polar growth continued, but DNA replication did not occur. 
The phenotype was most like that of SICl (substrate/subimit inhibitor of Cdc28) 
overexpression (26). Siclp prevents cell cycle entry into S by inhibiting Cdc28/Clb 
complex activity (33). Progression proceeds by destruction of Siclp by a Cdc34 
ubiquitin-conjugating enzyme. In addition, cdc4, cdc34, cdc53, and clbl-6 mutants 
also were similar in phenotype. CDC4 codes for a protein that contains copies of 
a motif foimd in J3-transducins (38) and CDC34 codes for a ubiquitin-conjugating 
enzyme (13). These phenotypic similarities suggested that Elmlp may play a role 
in cell cycle control or may be regulated at a particular time in the cell cycle by 
Cdc34p. Elmlp may be degraded through PEST sequences at a particular time in 
the cell cycle. That Elmlp kinase activity was not essential for display of this 
phenotype argues that Elmlp may be bifianctional, may be activated at a 
particular time in the cell cycle, may titrate away some factor necessary for cell 
cycle progression, or that Elmlp may be greatly overexpressed at levels that 
somehow are toxic to the cell. Thus, by some mechanism yet to be determined, 
GST-Elmlp overexpression may play a role in cell cycle progression. 
Elmlp overexpression was epistatic in combination with other elm 
mutants and Phdlp overexpression. Overexpression of GST-Elmlp could not 
be suppressed in combination with Phdlp overexpression. Results from these 
overexpression studies, two-hybrid studies andphdl elml-1 morphology studies 
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(7) suggested that ELMl and PHDl do not interact geneticsdly and, thus, may be 
in different pathways controlling pseudohyphal growth. Further studies to 
support this conclusion would include overexpression of PHDl under control of a 
galactose promoter. 
In GST-Elmlp overexpression in other elm mutants, GST-Elmlp was 
epistatic. General conclusions from this experiment are that Elmlp may function 
in a different pathway, ELMl may be downstream of these other elm mutants, or, 
once again, Elmlp levels may be excessive that the cell can not ftmction. More 
experiments with reversed epistasis will need to be done hs other mutants are 
cloned to better understand the results of these epistasis experiments. Two other 
elm mutants have been identified. One is CDC12/ELM13 coding for a 10-nm neck 
filament protein necessary for cytokinesis (2,16) and the other is 
GRR1/COT2/ELM4 coding for a protein with leucine-rich repeats that has diverse 
affects, including alteration of cell morphology and of transport of different 
molecxales (4, 6,10). The prodNevertheless, that elmd and elmll mciants 
expressing GST-Elmlp were not viable on galactose media and that elmlO 
expressing GST-Elmlp was extremely elongated, more elongated than D273 
expressing GST-Elmlp, on galactose media provided observations on additional 
genetic interactions between ELMl and the other elm mutants. Thus, results 
fi-om these epistatsis studies in conjionction with the synthetic-lethal and 
synthetic-slow genetic interactions between the elm mutants (2) may provide 
additional clues to ordering elm mutants in a pathway and to providing strategies 
to identify the genes coding other elm mutants. 
Does Ehnlp function as a cell cycle inhibitor? The overexpression 
phenotype of Elmlp correlated with the fusion of GST to the amino terminus of 
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Elmlp and with the expression of full-length Elmlp. (Jene fusion pCK36-Tl 
contained only a 43 amino acid deletion from the carboxy terminus, removing one 
half of a PEST sequence, yet failed to interfere with the cell cycle. Perhaps 
sequences in the very carboxy end of Elmlp are important for interaction with 
Cdc28p; the carbojQr terminus of Elmlp and cell cycle inhibitor Siclp are very 
similar in that they are quite acidic and contain PEST regions (26). In addition, 
that the ELMl roRNA is extremely low and Elmlp is maintained at low levels in 
the cell suggest that Elmlp may be involved in cell cycle control. In contrast, 
sequences in the very carboxy terminus of Elmlp may titrate out a factor 
required for Siclp degradation. Catalytic activity of Elmlp was not essential for 
the overexpression phenotype. Elmlp may be activated by Cdc28p at a 
particular time in the cell cycle and overexpression levels are just too high that 
they interfere with cell cycle progression. 
Elmlp may perform the same fimction as Siclp. Cells lacking Siclp are 
viable but have an increased frequency of broken and lost chromosomes and in a 
population of cell overproducing SICl, cell cycle progression is inhibited in only a 
subset of cells (26). These results suggest that other proteins may substitute for 
Siclp, Recently, Farlp has been identified as a potential inhibitor of Cdc28/Cln 
activity (27,35). Thus, Elmlp perhaps may be equivalent to Siclp or may be 
activated through association with Cdc28p. 
Additional experiments will need to be completed before the role of Ehnlp in 
the cell cycle can be defined. Possible experiments are as follows. If Ehnlp plays 
a role in cell (^cle progression, the ELMl transcript and gene product may be 
expressed in a cell cycle dependent manner. To answer this question, cell 
synchronization experiments would reveal if the ELMl transcript and gene 
101 
product were detectable in wild-type cells at a particular time in the cell cycle. 
Because Elmlp can only be detected as a fusion to GST, sequences in the amino 
terminus such as the PEST sequence may be important for stability. 
Experiments to examine the protein level and morphology of cells overexpressing 
an amino-terminal truncation of Elmlp imder control of the GALl promoter would 
define the relevance of amino-terminal sequences in Elmlp stability. Because 
expression of full-length Elmlp affects cell cycle progression, sequences in the 
carboxy terminus may directly interact with Cdc28p or may titrate away some 
factor essential for Siclp degradation and progression through the cell cycle. 
Experiments in which just the carbo:!gr terminus of Elmlp was expressed would 
define whether sequences in the carboy terminus interfere with cell cycle 
progression. Finally, if ELM 1 perhaps functions in the same pathway as SICl, 
CDC34, CDC4, and CDC53, genetic experiments such as overexpression of Siclp 
in an elml mutant and construction of a elml cdc34 temperature-sensitive 
mutant may indicated if Elmlp fimctions in the same pathway. 
Results fi:om these experiments showed that cell morphology was affected 
when Elmlp was present at levels that were detectable via immunoblot analysis 
and was full-length. Specifically, cells remained in Gl and budding and polar 
growth continued. Cells were uninucleate because nuclear division was not 
completed, and as a result, cytokinesis was not completed. Unlike cells 
overexpressing Siclp, these cells with an altered morphology were not overtaken 
by normal cells in the culttrre. Thus, Elmlp may play a role in cell cycle, but the 
pathway has not been resolved. 
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CHAPTER 4. Elmlp BINDS AND PHOSPHORYLATES 
RIBOSOMAL PROTEIN 2L IN VITRO AND IN VIVO 
A paper to be submitted to Genes and Development 
Carla Koehler and Alan Myers 
Abstract 
Elmlp is a novel serine/threonine protein kinase that regulates morphologic 
differentiation in the Saccharomyces cerevisiae. An interaction trap was used to 
identify potential Elmlp substrates and effectors. Of eight potential proteins 
identified, two were involved in translation and two were putative purine 
phosphoribosyltransferase homologs. Elmlp formed a complex with the product 
of one of the cDNAs isolated in the interaction trap screen in vitro. Specifically, 
the product of RPL2B, ribosomal protein (rp) 2L, expressed in coli was 
phosphorylated by purified Glutathione S-transferase-Elmlp fiision protein in 
vitro but not by a deletion derivative lacking 42 residues at the carboxy terminal 
end of Elmlp. Results from this study suggested that Elmlp may play a role in 
control of translation or nitrogen metabolism and that Elmlp may control 
pseudohyphal growth through modification of several proteins. 
Introduction 
Saccharomyces cerevisiae is dimorphic; it can grow in the yeast form or the 
pseudohyphal form (6,10,21,22). The yeast form is characterized by oval shape 
and by being imicellular. In pseudohyphae, the cells have an elongated shape and 
stay attached to each other presumably by their cell walls. The budding pattern 
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is Tonipolar in which daughter cells bud and rebud at the pole opposite their birth 
pole. This resulting change produces a filamentous, branched structure growing 
away fi:om the center of the colony. In addition, pseudohyphal cells are able to 
penetrate the agar. The switch in morphology from yeast form to pseudohjrphal 
form can be induced by nitrogen starvation in the presence of glucose (21). 
The gene ELMl is proposed to code for a function that in conditions of 
ammonia limitation acts in the series of events that result in conversion of the 
yeast form to the pseudohyphal form (5, 6). Recessive elml mutations cause a 
mutant growth state characterized by the formation of expanded, branched 
chains of elongated cells with enhanced ability to grow invasively tinder the 
surface of agar media. This phenotype, identical in several regards to 
pseudohyphal colonies of laboratory reference strains growing in low ammonia 
mediimi, occurs regardless of the nutrient conditions and independent of solid 
medium. Thus, the phenotype caused by elml mutations is referred to as 
constitutive pseudohyphal growth. 
Components of the pheromone response pathway are required for 
pseudohyphal growth in diploids and invasive growth in haploids (33,41). In diploid 
cells competent to grow as pseudohypae in nitrogen starvation conditions, 
mutations in STE2, STE3, STE4, STE18, KSSl, and FUSS had no discernible 
effect on pseudohyphal growth; in constrast, mutations in STE20, STEll, STE7, 
and STE12 suppressed the formation of pseudohyphae and invasion into the agar 
medivim (33). In haploid cells, invasive growth requires STE20, STEll, STE7, and 
STE12 (41). The role of I^Sl and FUSS however is complex and may suggest the 
existence of other MAP kinases specific for this pathway. Particularly, kssl 
FUSS mutants are defective for invasiveness, and ESSl fusS mutants exhibit 
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enhanced invasiveness (41). Mutants defective in both genes exhibit normal 
invasiveness. 
Proteins that interact with Elmlp either as substrates or regulators of 
Elmlp activity are likely to have important roles in control of pseudohyphal 
growth. To identify proteins that interact with Elmlp, the protein-protein 
interaction trsn, also referred to as the two-hybrid system, was used (18,19,23, 
54). This system has been used successfully to identify a substrate of protein 
kinase SNFl (54). The interaction trap is a yeast-based genetic assay to detect 
protein-protein interactions in vivo. One hybrid consisted of the DNA-binding 
domain (BD) of transcriptional activator GAL4 fused to Elmlp; the other hybrid 
consisted of a fusion between the transcriptional activation domain (AD) of GAL4 
and a yeast cDNA library. Interaction between BD-Elmlp and the protein coded 
by the AD-cDNA fusion reconstituted the function of the transcriptional activator 
GAL4 and caused transcription of a reporter gene containing upstream activation 
sequences (UAS) for the GAIA DNA-binding domain. We report the identification 
of eight proteins that potentially interacted with Elmlp. Possible mechanisms by 
which Elmlp regulates pseudohjrphal growth are discussed. 
Materials and Methods 
Media and genetic methods. The following media were used: YPD (1% 
yeast extract, 2% peptone, 2% glucose); SD (2% glucose, 0.7% yeast nitrogen base 
without amino acids, supplemented as required with leucine, tryptophan, histidine, 
methionine, uracil, lysine, and adenine at 20 |xg^ml each); SG (2% galactose, 0.7% 
yeast nitrogen base without amino acids, supplemented as required with 
axaxotrophy requirements listed above); SR (2% raflSnose, 0.7% yeast nitrogen 
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base without amino acids, supplemented as required with aiaxotrophy 
requirements listed above); SD supplemented with 25 mM 3-amino-l,2,4-triazole 
(3-AT, Sigma Chemical, St. Louis, MO). Solid media for yeast contained 2% agar. 
Yeast strains were cultured at 30®C. Yeast strains were transformed using the 
LiCl procedure (46,47). 
Nucleic acid manipulations. Recombinant DNA manipulations were 
performed xasing standard procedures (2,43). Nucleotide sequence analysis used 
the chain termination method (45). Immimoblot analysis used the ECL 
Chemiluminscence system (Amersham, Arlington Heights, IL) according to 
manufacturer's suggestions. Antibodies anti-GST (Molecular Probes, Eugene, 
OR.), monoclonal 12CA5 against the hemagglutinin (HA) epitope, and anti-Elmlp 
(described in Chapter 2) were used for detection of Elmlp; monolconal antibody 
anti-T7 (Novagen, Madison, WI) was used for detection of Elmlp-interacting 
proteins subcloned in vector pET23a (Novagen, Madison, WI) and expressed in E. 
coli. E. coli strain TG-1 (Amersham, Arlington Heights, IL) was used for 
amplification of plasmids and single-stranded DNA production. 
Strains and construction of alleles. S. cerevisiae strains used in this 
study are described in Table 1. Plasmids are described in Table 2 and 4. Strains 
Y187 and Y190, vectors pASCYH2 and pACT, and a yeast cDNA library cloned in 
the Xhol site in vector pACT were generously provided by Steve Elledge, Baylor 
Medical College (18,23). Plasmid pASCYH2 contained a 2\l origin of replication, 
TKPl and CYH2 alleles, and GAL4 (amino acids 1-147) DNA binding domain and 
plasmid pACT contained a 2|i origin of repUcation, LEU2 allele, and GAL4 (amino 
acids 768-881) transcriptional activation domain. 
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Table 1. S. cerevisiae strains used in this study. 
Strain Grenotype Source or derivation 
WAelmlH MATSL ura3 leu2 his3 trpl ade2 
elml::HIS3 
M. Blacketer 
Y690 MATSL!a leu2!Ieu2 ura3!ura3 
hisBlhisS [pHIS3GAL4] 
R. Deschenes 
Y190 MATa hisS trpl-901 ade2-101 
ura3-52 leu2-3,112, gal4A 
galSOA URA3::GAL4acZ, 
LYS2::GAL-HIS3 cyh2 
S. EUedge 
Y187 MATahis3 trpl-901 ade2-101 
ura3-52 leu2-3,112, met'> gal4A 
galSOA URA3::GAL-lacZ 
S. EUedge 
Table 2. GAIA gene fusions constructed in this study. 
Name Insert AUele Source Cloning vector 
pCK63 
pBD-ELMl 
pBD-MGPl 
pBD-RHOl 
pAD-ELMl 
2.2 kb ELMl 
BamHJ/BarnHl 
0.28 kb 
NdeVNdel 
1.9 kb 
NcoVBamEl 
0.7 kb 
BgllUBglll 
BD-ELMl 
BB-MGPl 
pCK37 
pCK34 
pSHL46 
2.2 kb AD-ELMl pCK34 
BarnHJ/BamJil 
pASCYH2 
pCK63 
(pASCYH2) 
pASCYH2 
BD-RHOL pUCRHOl pASCYH2 
pACT 
Ill 
Gene fusion pBD-ELMl was constructed as follows. A 2,200 bp BamMl 
fragment contairdng the entire ELMl coding region was removed from pCK37 anH 
subcloned into vector pASCYH2 to construct pCK63, in which ELMl was fused to 
the 3' end of the GAL4 BD, but not in the correct reading frame. To create an in-
frame fusion, both pCK63 and pCK34 were digested with Ndel. A 300 bp 
fragment from pCK63 was removed including the out-of-frame fusion and a 280 
bp fragment from pCK34, which places ELMl in frame with the GAL4 BD was 
inserted to construct pBD-ELMl. DNA sequencing using the primer CK2 5'-
GAGCGTTATCGrGG-3' confirmed that pBD-ELMi fiision was in the correct 
reading frame. 
Gene fusion pBD-MGPl was constructed by subcloning a 1,900 bp 
NcoVBamSl fragment from pSHL46 (50) into the multiple cloning region of 
pASCYH2. MGPl codes for mitochondrial G protein in S. cerevisiae; gene fusion 
BD-MGPl was used as a control to determine if the BD-ELMl fusion was 
expressed (50). 
Gene fusion pBD-RHOl was constructed by subcloning a 700 bp B^lII 
fragment from pUC-RHOl (28) into a BamHI site in the multiple cloning region of 
pASCYH2. RHOl codes for a yeast GTPase that regulates yeast cell morphology; 
gene fusion BiD-RHOl was constructed as a control to determine if the BH-ELMl 
fusion was expressed. 
Gene fusion pAD-ELMl was constructed by subcloning a 2,200 bp BamHI 
fragment containing the entire ELMl coding region from pCK34 into vector pACT 
(18). DNA sequencing using the primer CK2 5'-GAGCGTTATCGrGG-3' confirmed 
that pAD-ELMI fusion was in the correct reading frame. 
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Grene fusions in which inserts from interacting GAIA AD clones were 
subcloned into pET23a (Novagen, Madison, WI) for in vitro binding assays and 
phosphorylation assays with Elmlp were constructed as described in Table 4. 
Essentially, inserts were removed asXhol fragments from the GAIA AD clones 
and subcloned into vector pET23a, in which the fragment was tagged at the amino 
terminus with 15 amino acids from T7 gene 10. This tag was recognized by 
monoclonal antibody anti-T7, 
Gene fusions in which the insert was switched from the GAL4 AD in pACT 
to the GAIA BD in pASCYH2 were constructed as described in Table 4, 
Essentially, inserts were removed from the GAIA AD domain as Bglll fragments 
and inserted in frame into a BamSl site 3' of the GAIA BD. Criterion for 
switching genes coding for Elmlp-interacting proteins were that the gene 
fragment could not contain an internal Bglll site. 
Functional analysis of ELMl in yeast. ELMl gene fusions were tested 
for functionality based on their ability to restore the constitutive pseudohyphal 
phenotype of elml to the yeast-like phenotype. Strain WAslmlH (6) was 
transformed with pBD-ELMl, pAD-ELMl, and pASCYH2 to tryptophan 
prototrophy. Transformants were patched onto SD lacking tryptophan and 
scored for the ability to complement the mutant phenotype six hours after 
patching. Cells from an agar dish were suspended in a drop of 1.2 M sorbitol or 
distilled water and observed at 400X magnij5cation using Nomarski optics. 
Library screening. Y190 was transformed to tryptophan prototrophy 
with pBD-ELMI according to Schiestl and Gietz (1989). A single transformant 
was selected, verified for auxotrophic markers, and grown in SD lacking 
tryptophan; this strain then was transformed with a yeast cDNA library in vector 
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pACT (18,23,46). The transformation mix was plated on 15-cm dishes 
containing SD -Trp, -Leu, -His, +25 mM 3-AT, and incubated at 30°C for 3-5 days. 
His+ colonies were screened for J3-galactosidase activity using a filter lift assay (9). 
Briefly, colonies were transfeixed on nitrocellulose membranes, permeablilized by 
fi-eezing in liquid nitrogen, and overlaid on Whatman IMM paper saturated with Z-
Buffer containing X-gal (5 ml/dish) (9). Membranes were incubated at 30°C for 
one hour to overnight. Colonies that turned blue were scored positive and were 
patched onto a master plate for further analysis. 
Elimination of false positives. Positive colonies were tested further to 
determine if the fi-galactosidase activity depended on BD-Elmlp interacting with 
the gene product of the AD-cDNA fusion. To select for loss of pBD-ELMl, 
Colonies were passed through two rounds of selection on SD media with 10 mg/ml 
cycloheximide and tryptophan but lacking leucine to select for loss of pBD-ELiMl. 
Colonies with only pACT-cDNA plasmids were tested individually using the filter 
lift assay to determine if they turned blue. Those that did not turn blue were 
mated to the following testers in strain Y187: pBD-CDK2, pBD-SNFl, pBD-p53, 
pBD-lamin (provided by S. Elledge) (18,23), and pBD-RHOl. The Y190/Y187 
diploids were selected on SD -Leu, -Trp and assayed for blue color indicative of fi-
galactosidase activity using the filter lift assay. Those colonies that were white 
and did not exhibit J3-galactosidase activity were considered positive; the pACT-
cDNA gene fusions were isolated for further analysis. 
Recovery of plasmids from yeast. Total DNA from yeast was prepared 
(2) with minor modifications. After isolation, yeast DNA was precipitated in 
ethanol and resuspended in 20 ijl water. 5 |J1 of DNA was incubated with 50 pi of 
competent TG-1 cells (2) and transformed by electroporation in 0.2 cm cuvettes 
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with a Bio-Rad E. coli Piilser (Bio-Rad, Hercules, CA) according to the 
manufacturer's specifications. 
Sequence analysis. Plasmids yielding proteins that interacted with 
Elmlp were sequenced at the fusion site with the GAL4 AD using primer 5'-
GGAATCACTACAGrGG-3', which hybridized to GAL4 codons 860-854. Sequence 
analysis and data base homology searches used the Genetics Computer Group 
software packing (Genetics Computer Group, Madison, WI). 
In vitro binding assay. Gene fusions in which the interacting proteins 
were subcloned into pET23a (Table 4) were transformed for induction into the E. 
coli expression strain BL21(DE3)pLysS (Novagen, Madison, WI) with the 
exception of pET-HSP82 and pET-EFla. pET-HSP82 was transformed into 
BL21(D3); pET-EFla was transformed into several BL21(DE3) hosts but 
expression was not detected. Stains were grown in LBmedia containing 200 |ig/ml 
ampicillin and 34 ^g/ml chloramphenicol, except medium for pET-HSP82 strain 
did not have chloramphenicol because pLysS was not present. Cultures were 
grown to an O.D.600 of 0.6 and then induced with addition of IPTG to a final 
concentration of 0.4 mM. E. coli cells were harvested, washed in 10 mM Tris-HCl, 
pH 7.5, and pellets were fi-ozen at the following times after induction. For pET-
HSP82 and pET-RPL2, cioltures were harvested at 8-10 hours post-induction; and 
for pET-287 and pET-317, cultures were harvested at 16-18 hours post-induction. 
Frozen pellets were resuspended in 10 mM Tris-HCl, pH 7.5,1 mM EDTA, 100 
mM NaCl, 0.5% Triton X-100,1 mM PMSF and lysed by sonication. Samples 
were spim at 10,000 xg and the supernatant was fi:ozen in ahquots at 10 mg/ml in 
10% glycerol at -70°C for further use. In addition, the vector pET23a was induced 
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under the same conditions. As controls, lysates from uninduced strains also were 
prepared. 
For the in vitro binding assay, GST and GST-ELMl fusion proteins were 
obtained as described in Chapter 2. Approximately 30 |j1 of beads containing GST-
Elmlp protein, or GST as a control, were incubated in a volume of 500 pi PBS 
containing 500 |ig of E. coli lysate. The reaction was incubated for 30 minutes at 
25°C with gentle rocking. The beads then were washed 4 times with PBS, 
resuspended in IX Laemmli loading buffer, and immimoblot analysis was 
performed using an anti-T7 tag (Novagen, Madison, WI) to detect whether a gene 
fusion was expressed from the pET23a-Elmlp-interacting protein hybrid. 
In vitro phosphorylation assays. In vitro phosphorylation assays were 
as described in Chapter 2. For substrate, E. coli lysate was added at a final 
concentration of 5 mg/ml. 
Polyacrylamide gel electrophoresis and autoradiography. Protein 
samples and phosphorylation assays were separated on 10% SDS-polyacrylamide 
gels (29). Staining was accomplished with Coomassie Blue R-250 and the gels 
destained in 7.5% acetic acid, 5% methanol. Kodak XAR-5 film was exposed to the 
dried gel for autoradiography. 
Results 
Isolation of Ehnlp-interacting proteins. The interaction trap was first 
described by Fields and Song (13,20). Here, we used a modification of this system 
(18,23) to identify genes coding for proteins that associate with Elmlp in vivo. 
One hybrid was a fusion between the GAL4 DNA binding domain (BD) and the 
ELMl coding region, named pBD-ELMl, and the protein product of this gene 
fusion was termed BD-Elmlp The second hybrid was a fusion between the GAL4 
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transcriptional activation domain (AD) in vector pACT and a yeast cDNA libraiy 
(provided by S. Elledge); these constructs were termed pAD-cDNA. Co-
transformation of pBD-ELMl with the pAD-cDNA library into strain Y190 
followed by assays for fi-galactosidase activity identified proteins that interacted 
with Elmlp. 
To assess the potential of the interaction trap as a screen to identify 
proteins that interacted with Elmlp, pBD-ELMl was tested to determine if BD-
Elmlp activated transcription of the B-galactosidase gene and if the BD-Elmlp 
was fimctional based on ability to restore constitutive pseudohyphal growth to 
yeast-like growth in an elml mutant. In strain Y190, the protein expressed fi*om 
pBD-ELMI did not activate transcription alone or in combination with the empty 
vector pACT because colonies expressing these gene fusions were not blue in the 
presence of X-gal, indicating that B-galactosidase activity was not present (data 
not shown). In addition, strain WAeZm JjH" grew in the yeast-like form when 
transformed with pBD-ELMI, but grew constitutively as pseudohyphae when 
transformed with the empty vector pASCYH2 (Fig. 1). To determine if the BD-
Elmlp was detectable, inmiunoblot analysis was performed on strain Y190 
expressing pBD-ELMl xising anti-Elmlp and anti-HA, which recognized the 
hemagglutinin tag placed between the GAL4 BD and ELMl. The ELMl hybrid 
protein, however, was not detectable with either antibody. Even in 
immimoprecipitation assays with anti-HA, the ELMl hybrid protein was not 
detectable but control proteins expressed from gene fusions in pBD-RHOl and 
pBD-MGPl were detectable. Thus, even though BD-Elmlp was not detectable, 
the interaction trap had potential to identify Elmlp-interacting proteins becavise 
BD-Elmlp folded into a functional confirmation to restore constitutive 
Figure 1. pBD-ELMl and pAD-ELMl complement an elml mutant. pBD-
ELMl, pAD-ELMl, and control pASCYH2 were transformed into strain 
WAelmlH; transfonnants were patched on SD agar media and individual cells 
were scored 12 hovirs later. Cells were viewed with Nomarski optics. 
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pseudohyphal growth to yeast growth in an elml mutant, levels of the protein 
were adequate to restore the pseudohyphal phenotype, and most importantly, BD-
Elmlp did not activate transcription of the lacZ reporter gene.. 
Yeast strain Y190 first was transformed with pBD-ELMl and then with a 
pACT yeast cDNA library. Approximately 5 x 10^ transformants were placed 
under selection and His+ surviving colonies were screened for their ability to 
produce J3-galactosidase, based on the presence of blue color using the filter lift 
assay (9). From 260 His+, blue colonies, 41 contained plasmids that activated 
lacZ transcription only in the presence of pBD-ELMI and did not activate 
transcription alone (Table 3). These fell into 8 classes, which was determined by 
sequence analysis and data base homology searches (Table 3,4). In addition, the 
nucleotide fiision site was determined by sequence analysis and the size of the 
cDNA insert was determined by restriction with Xhol followed by size analysis on 
an agarose gel (Table 4). These plasmids were named based on the yeast cDNA 
they contained or, in the case of those that were not identified previously, given a 
ntmiber. Thus, eight proteins were identified that seemingly complexed with BD-
Elmlp in vivo and this complex activated transcription of the ZacZ reporter gene 
as detected by the presence of fi-galactosidase acitivty. 
Description of Elmlp-interacting proteins. Two of the Elmlp-
interacting proteins (Table 3,4) were involved in translation. The first was gene 
TEFl that codes for the a subimit of cytoplasmic elongation factor 1 (EF-1) (15, 
39). The cDNA was nearly full-length and the insert was 1.1 kb (Table 4). EF-1 is 
required for the GTP-dependent binding of animoacylated tRNA to the ribosomal A 
site and participates in the proofi*eading of the codon-anticodon match. EF-1 is 
composed of three subunits: EF-la, EF-1J3, and EF-ly. EF-la is a 50 kD 
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Table 3. Qualitative assay of J3-galactosidase activity of yeast colonies in 
strains expressing GAL4 BP fusions and GAL4 AD fdsions. 
GAIA BD fusion GAL4 AD fusion Colony Color 
SNFl SNF4 Blue 
SNFl None White 
ELMl None White 
ELMl TEFl Blue 
None TEFl White 
lamin^ TEFl White 
ELMl RPL2B Blue 
None RPL2B White 
lamin^ RPL2B White 
ELMl 287 Blue 
None 287 White 
lamin^ 287 White 
ELMl 317 Blue 
None 317 White 
lamiri)^ 317 White 
ELMl PFKl Blue 
None PFKl White 
PFKl White 
ELMl HSC82 Blue 
None HSC82 White 
laming HSC82 White 
ELMl 29 Blue 
None 29 White 
lamiri)^ 29 White 
ELMl 253 Blue 
None 253 White 
lamin^ 253 White 
^The color of individual yeast colonies in the presence of X-gal was examined using 
the filter lift assay of Breeden and Nasmyth (1985). 
'^Other false positive indicator GAL4 BD gene fusions examined were ED-SNFl, 
BD-CDK2, BI)-p53, and BD-RHOl and all colonies were white. 
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Table 4. Gene fusions containing Elmlp interacting proteins. 
pAD clone Protein Fusion site 
(nt #) 
Insert size pET23a 
fusion^ 
pASCYH2 
fusion^ 
pAD-TEFl EF-la 37 1.1 kb pET-EFla pBD-EFla 
pAD-RPL2B RPL2 -3 1.2 kb pET-RPL2 
(40 kD) 
pAD-287 adenine PRT 
homolog 
1 0.8 kb pET-287 
(27 kD) 
pAD-317 ORFC ND 1.0 kb pET-317 
(35 kD) 
pAD-PFKl PFKl 1978 1.1 kb 
pAD-HSC82 HSP82 538 1.9 kb pET-HSP82 pBD-HSP82 
(58 kD) 
pAD-29 ORFd 
5' of WBPl 
19 0.8 kb 
pAD-253 ORFd 
5' of RAD51 
16 0.8 kb 
^Those not listed below have not been subcloned into pET23a. Observed 
molecular weight of proteins that were expressed is indicated. 
^Those not listed below have not been subcloned into pASCYH2. 
'^ORF that has not been sequenced in yeast but is homologous to hypoxanthine-
guanine phosphoribosyltransferase (PRT) in another species. 
^ORF that has been sequenced in Saccharomyces cerevisiae, but function is not 
known. 
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polypeptide usually present as a monomer that is homologous to bacterial EF-Tu, 
a GTP-binding protein (16), In yeast, two unlinked genes TEFl and TEF2 code 
identically for cytoplasmic EF-la (15,39,48). The ORFs of these genes differ in 
only two positions, although their 5'- and 3'-flanking regions differ considerably. 
Both the TEFl and TEF2 genes are efficiently transcribed at the same level (38). 
The presence of either TEF gene alone is sufficient to support normal growth 
rates, whereas disruption of both TEF genes is lethal. TEF gene dosage (14) and 
mutations in TEF genes affect translational accuracy (44). 
The second was gene RPL2B that codes for ribosomal protein (rp) L2 (40). 
The cDNA was full-length and the insert was 1.2 kb (Table 4). Ribosomal protein 
L2 is a basic protein that has been crosslinked to rDNA in the 60S subunit and is 
homologoias to Xenopus laevis rp LI (40). Two genes RPL2A and RPL2B are 
present per haploid genome and code for L2 proteins that differ in only a few amino 
acids (34). Both genes are fimctional but in the mRNA pool, the L2A copy makes 
up 72% of the mRNA. Disruption of both genes is lethal, whereas disruption of 
RPL2A results in a reduced growth rate and disruption of L2B has no phenotypic 
effects (34). Phosphorylation of ribosomal proteins has been reported (30). 
Although the physiological significance is not clear, phosphorylation levels may be 
influenced by growth conditions and may be a regulatory mechanism for 
controlling ribosomal fimction (30). 
Two of the genes 287 and 317 coded for proteins that may be 
phosphoribosyltransferase homologs (PRTs). PRTs have not been cloned in yeast, 
but hypoxanthine-guanine PRT mutants have been identified (52). The 287 cDNA 
was full-length and the insert was 0.8 kb (Table 4). The ORF was located on 
chromosome XIII (Accession No. Z46659) by the yeast genome sequencing project 
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and was identified as a putative adenine PRT homolog, based on amino acid 
sequence comparison with adenine PRTs in other species. The 317 ORF was not 
sequenced in yeast but the cDNA was 1.0 kb (Table 4) and a 35 kD protein was 
expressed in E. coli. A preliminary database search using the first 150 nucleotides 
revealed homology with Plasmodium falciparum hypoxanthine-guanine PRT 
mRNA (11). Further sequencing of the 317 ORF will be needed to better assess 
the identity of this cDNA. 
One of the other interacting proteins was the a subimit of 
phosphofi*uctokinase-l (PFKl) (25). The cDNA fragment was approximately half 
the size of the gene; the fusion point was at nt 1978. An additional cDNA was 
identified with a fiision point at nt 1951, indicating that at least two independent 
cDNAs were identified that perhaps interacted with Elmlp in vivo. PFK is an 
octamer comprised of four regulatory a-subtmits and four cataljrtic B-subunits 
(24). In yeast, the J3-subunit was phosphorylated in a cyclic AMP-independent 
manner which was accompanied by stabilization against proteolytic degradation 
(27). Phosphorylation has been reported on the a-subimit in other species (4, 36, 
55). PFKl activity is regulated during the cell <ycle; the activity rises 8-fold fi:om 
the beginning of bud formation to the end of S and then activity drops markedly 
during the later stages of the cell cycle (51). 
One of the other interacting proteins identified in this screen was HSC82 
cDNA coding for heat shock protein (hsp) 82 (8), a member of the Hsp90 family 
(31). As with PFKl, the cDNA was not full-length; the fusion site was nucleotide 
538 and the cDNA was 1.9 kb in length (Table 4). HSC82 and HSP82 are two 
members of an esser cial HSP82 gene family. HSC82 is expressed constitutively 
at a very high level and is moderately induced by high temperatures (8). Although 
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little is known about the biochemical associations of hsp82 in yeast cells, the 
hsp90 has been reported to associate with several different protein kinases such 
as protein kinase C, eIF2a kinase, and transforming kinases in virus-infected cells 
(8,32,42) in mammalian and avian cells in addition to interacting with calmodulin, 
actin, tubulin, and steroid receptors (31). Recently reported, the formation of 
active Weel protein kinase that regulates the length of G2 in S. pombe by 
carrying out the inhibitory tyrosyl phosphorylation of Cdc2-cyclin b kinase 
requires an interaction with an Hsp90 homolog (1). 
Finally, two of the Elmlp-interacting proteins were coded by genes that 
have been sequenced but have no assigned function. cDNA 29 was identical to an 
ORF located 5' of wheat hemagglutinin binding protein (WBPl) (49). cDNA 253 
was identical to an ORF located 5' of RAD51 (3). Both of these cDNAs were 
nearly full-length (Table 4). Data base searches failed to identify homologous 
proteins. 
Expression of Elmlp-interacting proteins in E. coli. To verify that 
Elmlp interacts in vivo with these proteins, examination of in vitro interactions 
has been started. The genes from pAD-RPL2B, pAD-TEFl, pAD-HSC82, pAD-
287, and pAD-317 were subcloned as Xhol fragments into E. coli expression 
vector pET23a (Table 4) and induced with IPTG to express proteins with a T7 tag 
on the amino terminus as described in the Materials and Methods. Total E. coli 
lysates were examined in immimoblot analysis and four proteins were detectable 
with anti-T7 (Fig. 2) in IPTGr-induced cells. The approximate molecular weights 
were rp L2,40 kD; 287p, 27 kD; 317p, 35 kD; Hsp82 was predicted to be 58 kD in 
molecular weight, but many bands were present possibly because the protein 
associated with other coli proteins or was degraded. The protein EF-la was not 
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Figure 2. Expression of fotir Elmlp-interacting proteins in E. coli. A subset 
of the proteins that interact with Elmlp in vivo were subcloned into pET23a and 
expressed as fusions with an amino terminal T7 tag as described in the Materials 
and Methods, 20 |ig of total E. coli lysate was loaded per lane. Immunoblot 
analysis using anti-T7 identified proteins of the expected size. E. coli lysate from a 
strain transformed with the empty vector pET23a was used as a control. 
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detected. Thus, the fusion between GAL4 AD and the yeast cDNAs from the 
pACT yeast cDNA library occurred in the correct frame and resulted in the 
expression of GAL4 AD fusion proteins. 
Elmlp binds to rp L2 in vitro. To confirm the in vivo results, binding 
between Elmlp and the Elmlp-interacting proteins was tested. Total E. coli 
lysates from strains shown in Fig. 2 were incubated with gluthathione agarose 
beads containing GST-Elmlp, GST-Elml-Tl the Elmlp fusion protein that lacks 
42 amino acids from the carboxy terminus (Chapter 2), or control GST, followed 
by washing and immimoblot analysis with anti-T7 antibody. GST-Elmlp 
specifically botmd to rp L2 in vitro in IPTG-induced cells (Fig. 3). Proteins from 
lysates of uninduced cells could not be detected with anti-T7 for association with 
Elmlp (data not shown); proteins from lysates of strains carrying the empty 
vector pET23a also were not detected as binding to GST-Elmlp. Interestingly, 
other proteins expressed from pET-HSC82, pET-317, and pET-258 were not 
detected as binding to Elmlp. Protein rp L2 from E. coli lysates bound to both 
GST-Elmlp and GST-Ehnlp-Tl. 
To test if any of these interacting proteins were potential substrates of 
Elmlp, in vitro phosphorylation assays were done using GST-Elmlp on 
glutathione agarose beads with total E. coli lysate. Results from preliminary 
experiments showed that Ehnlp phosphorylated rp L2 in vitro in IPTG-induced 
cells (Fig. 4). This phosphorylated protein was not present in E. coli lysates from 
uninduced cells. In addition, a protein the same size on the same membrane 
cross-reacted with anti-T7 in lysates from IPTGr-inudced cells only. In 
phosphorylation assays, a non-specific band was present in both IPTG-induced 
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GST Fusion Protein: 
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G: pEGST 
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Tl: pCK36-Tl 
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Figure 3. Elmlp binds to rp L2 in vitro. In vitro binding assays were done 
as described in the Materials and Methods. GST-Elmlp, GST-Elmlp-Tl, and 
control GST on glutathione beads purified from yeast were incubated with E. coli 
lysate from the four expressible proteins identified in Figure 2 at 25°C for 30 
minutes, followed by washing, and then loaded onto an SDS-PAGE gel. 
Immunoblot analysis with anti-T7 detected the presence ofE. coli cDNA fusion 
proteins. As a control, an E. coli strain transformed with pET23a was used. 
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Figure 4. Elmlp phosphorylates rp 2L in vitro. Phosphorylation assays as 
described in the Materials and Methods were done in which E. coli lysate from 
strains carrying pET23a (control) or pET-RPL2 was incubated with piirified GST-
Elmlp or GST on glutathione beads from yeast strains. The left panel shows the 
results of in vitro phosphorylation assays. Phosphorylated products were 
separated on a gel and transferred to a nitrocellulose membrane for 
autoradiography. The right panel is an immunoblot with anti-T7 on the same 
membrane as the phosphorylation assays. 
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cells and uninduced cells, indicating the presence of an endogenous E. coli protein 
kinase. 
The other proteins that were induced in E. coli (Fig. 2) seemingly were not 
phosphorylated by Elmlp or were not bound by Elmlp. These, however, are 
preliminaiy restdts. These experiments will be repeated using Elmlp purified 
from insect cells. In addition, a construct has been made placing ELMl in the 
GAL4 AD plasmid and constructs are being made to place the Elmlp-interacting 
cDNAs in the GAL4 BD plasmid so that the interactions can be tested in reverse. 
Elmlp, expressed as a GAL4 AD fusion protein in pAD-ELMl also complemented 
the constitutive pseudohyphal phenotype of an elml mutant and the cells grew 
with a yeast-like morphology (Fig. 1) and transcription of the reporter gene lacZ 
was not activated (data not shown); this illustrates that switching Elmlp and the 
interacting proteins to verify interactions in the reverse orientation is feasible. 
Thus, these results are preliminary and the interaction of Elmlp with these 
proteins identified by this technique will be continued. 
Discussion 
The interaction trap has been used as a genetic screen to identify proteins 
that specifically interact with Elmlp in vivo. Elmlp was not detectable when 
fused to the GAL4 BD but did complement the elongated phenotype an elml 
mutant so that the ceEs were oval-shaped. From this screen, eight cDNAs were 
identified; two of these cDNAs, RPL2B and TEF,1 were involved in translation and 
two were putative PRT homologs. The others were PFKl, HSC82, and two 
\xiiidentified ORFs. In addition, four of these hybrid proteins were fused in frame 
based on the ability of subcloned Xhol fragments to be expressed as proteins of 
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the predicted moleciilar weight in E. coli. To further confirm the in vivo interaction 
between Elmlp and rp L2, Elmlp bound rp L2 present in E. coli lysates in vitro 
and phosphorylated rp L2 in vitro. 
The results reported here define proteins that may be substrates or 
efiectors of Elmlp in vivo. Continued in vitro experiments like those with Elmlp 
and rp L2 will be done to determine if the proteins identified in the interaction 
screen touch Elmlp. 
A basic question, however, is whether these proteins identified with the 
interaction trap reflect the identity of true Elmlp-interacting proteins in vivo. 
Genetic evidence suggested that Elmlp acts further downstream in a 
pseudohyphal repression pathway or a yeast-form activition pathway (Chapter 3, 
(6). In addition, the levels of Elmlp in the cell are extremely low and the protein 
has sequences shared by other proteins that have a short half-life or are regulated 
in a cell-cycle dependent manner. Morphology studies of Elmlp overexpression 
suggested that Elmlp may be involved in the cell cycle, but the mechanism was 
not clear (Chapter 3). If this information is pieced together with the information 
fi'om the interaction trap, a general model can be constructed (Fig. 5). In this 
model, Elmlp may be activated by a Cdc28/cyclin complex at a particular time in 
the cell cycle. Cdc34p may trigger Elmlp degradation at another point in the cell 
cycle through the ubiquitin pathway (26). Once activated, Elmlp may complex 
with Hsp82; Hsp82 is a member of the nuclear chaperone family that binds to 
specific proteins in the cell (8). Hsp90 plays a crucial role in the fimction of steroid 
receptors by shuttling between the cytoplasm and nucleus (7). Hsp90 is 
physically associated with inactive forms of the receptor and is reqxaired for 
receptor activation. Analogous to steroid receptors, Hsp82 may shuttle Elmlp 
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Fig. 5. Proposed model illustrating the mechanism by which Elmlp may 
regulate pseudohyphal growth. PRTs are phosphoribosyltransferases 
between the cytoplasm and nucleus and may play a role in activation of the 
protein or may regulate interaction of Elmlp with cell cycle elements. 
Once activated, Elmlp may then phosphorylate or modify other proteins 
identified in the interaction trap such as EF-1, PFKl, the PRT homologs, and rp 
2L. During cell (ycle, Cdc28 regulates bud emergence, spindle pole body 
duplication, and DNA repUcation; many downstream targets most likely are 
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activated and timing in the cell cycle for processes such as translation, glycolysis, 
and nucleotide salvage is important. Two common features among the proteins 
identified in the interaction trap are that they are involved in general cellular 
pathways including nitrogen metabolism, carbon metabolism, and translation, and 
that they have common UAS for transcription factors Abflp and/or Raplp (17, 
53). Elmlp may regulate morphologic diflferentiation by acting on several 
components believed to be downstream in the pseudohyphal pathway. 
One major question is why were proteins like Cdc28p not identified in the 
interaction screen. One possibility may have been poor representation in the 
cDNA library. The other possibility could be that Cdc28p did not interact directly 
with Elmlp; rather the interaction may depend on another protein such as one of 
the unidentified ORFs or Hsp82. This has been reported for interaction between 
scdl with rasl and cdc42p in S. pombe (12). Specifically, scdl interacted with 
rasl and cdc42p in the two-hybrid system only when scd2 was expressed from 
another plasmid. 
Results fi:om the genetic protein-protein interaction screen provide 
additional clues to the fimction of Elmlp in vivo. Further experiments will confirm 
whether Elmlp interacts with these proteins in vivo. One such experiment is the 
isolation of ribosomes and immunoblot analysis with anti-Elmlp to see if Elmlp 
co-fi'actionates with ribosomes in vivo. In addition, testing for interaction between 
constructs in which Elmlp and the interacting proteins are reversed in the GAIA 
BD and AD plasmids will confirm that the interaction is not artifactual. Thus, 
restalts fi-om the interaction trap have presented additional clues to determining 
the fimction of Elmlp in vivo. 
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CHAPTER 5. CONCLUSIONS 
Summary 
Results from this project showed that the product of the ELMl gene codes 
for a novel serine/threonine protein kinase that regulates cellular dimorphism in S. 
cerevisiae. Elmlp possesses protein kinase activity in vitro and in vivo. This 
cataljTtic activity is essential for growth in the yeast form as mutagenesis in 
which an essential catalytic lysine residue is changed conservatively to arginine 
results in inability to grow in the yeast-like form. In addition, Elmlp is a 
serine/threonine protein kinase because it autophosphoiylates on serine and 
threonine residues. Potential substrates were identified in phosphorylation assays 
in vitro with Elmlp purified from insect cells. Interestingly, one of the proteins 
that is phosphorylated is the same size as ribosomal protein 2L which was 
identified as a protein that Elmlp may interact with in vivo. Elmlp seemingly is 
tightly regulated in yeast cells. The ELMl transcript is not abimdant and 
essentially only detectable in conditions of overexpression. Elmlp was only 
detected when glutathione S-treinsferase was fused to the amino terminus. 
Analysis of the ELMl protein sequence revealed the presence of PEST sequences, 
which have been implicated to play a role in protein turnover, in the amino and 
carboxy termini. Thvis, Elmlp may play a critical role in the cell because the 
protein is tightly regulated. 
Because Elmlp affects cellvdar morphology, the role of Elmlp 
overexpression on morphology was examined. When GST-Elmlp was present, the 
morphology of the cells was aberrant. Cells were blocked in Gl, but continued to 
bud. Nuclei did not divide but instead were stuck at the junction between the 
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mother and daughter. As a result, cytokinesis also was defective. Interestingly, 
the presence of this phenotype did not depend on catalsddc activity of Elmlp, but 
rather on the presence of sequences located within 43 residues at the carboxy 
terminus. This phenotype was not suppressed in the other elm mutants, but 
other genetic interactions were identified. In addition, this overexpression 
phenotype was also dominant in Phdlp overexpression, a positive regulator of 
pseudohyphal growth. 
To begin to identify effectors and targets of Elmlp, a genetic protein-protein 
interaction trap was constructed and several potential Elmlp-interacting proteins 
were identified. Of eight gene products, two played a role in translation and two 
played a role in nitrogen metabolism. Specifically, Elmlp interacted with the 
RPI2B gene product in vitro and in vivo. Continued investigations wiU reveal 
whether Elmlp interacts with the other protein products including elongation 
factor 1-a, hsp90, two phosphoribosyltransferase homologs, phosphofhictokinase-
1 and two previously tmidentified ORFs. 
Discussion 
The dimorphic transition in Saccharomyces cerevisiae from yeast-Hke growth 
to filamentous, pseudohyphal growth occurs in response to nitrogen starvation in 
the presence of glucose. The characterization of Elmlp fiinction was carried out 
with the goal of determining the pathway by which Elmlp regulated pseudohyphal 
growth. Previous results indicate that many genes are involved in this process (6). 
Results presented here confirm that Elmlp does play a role in the regulation of 
pseudohyphal growth but that the role of Elmlp is complex. 
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Results from the biochemical analysis reveal that catal3rtic function of 
Elmlp is essential for growth in the yeast form. However, the protein is tightly 
regulated and not very abundant. This suggests that Elmlp may be regulated in 
a cell cycle-dependent maimer. Many proteins such as Gcn4p, Siclp, and the 
CLN proteins contain PEST sequences and are degraded in a Cdc34p-dependent 
ubiqmtin pathway (34,46, 74,101). Whether this is the fate of Elmlp remains to 
be determined. Futtire experiments to study regulation of Elmlp expression at 
the translational level and post-translational level may provide insight into Elmlp 
regulation mechanisms. 
Results from morphological analyses are very interesting. Overexpression 
of Elmlp affects cell cycle; specifically Elmlp is acting as an inhibitor of 
Clb/Cdc28 activity and preventing progression into S in the cell cycle in a manner 
perhaps similar to Siclp (87). This phenotype is dependent on the presence of full 
length Elmlp and independent of catalytic activity. Additional genetic 
experiments with other cell cycle regulators must be completed before the role of 
Elmlp in cell cycle control can be determined. 
Finally results from the protein-protein interaction trap indicate that 
Elmlp may play a role in control of translation. Elmlp may be located on the 
ribosome. Elmlp may sense changes in nutritional status or nitrogen levels and 
respond by, among other functions, altering translation to regulate pseudohyphal 
growth. Continued investigations to determine whether Elmlp interacts with the 
other proteins identified in the interaction trap will shed light as to the role of 
Elmlp in the yeast cell. 
Data presented here are the resialts from many different approaches to 
answer the question of what the role of Elmlp is in pseudohyphal growth. While 
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clear cut answers have not been obtained, general ideas of the role of the novel 
serine/threonine protein kinase Elmlp in pseudohyphal growth have been 
presented. These results will serve as a basis to design fiarther experiments to 
understand the mechanism by which Elmlp regulates pseudohyphal growth. 
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APPENDIX 
Cell Culture Techniques 
(adapted from Ciirrent Protocols) 
Cells 
We have 3 types of insect cells available. They are Sf9, Sf21, and 5B14 
(equivalent to Invitrogen High Five cells). These cells are derived from Spodptera 
frugiperda ovary cells. Cells can be grown at room temperature or in an 
incubator at 28 C (do not add C02)-
Advantages of Sf21 are that they are slightly larger than Sf9. They are better for 
plaquing. These are the best cells for routine use. 
Advantages of 5B14 are that these cells grow extremely fast and secrete up to 5 
times more protein into the medium. These cells should be grown in 10% FCS. Do 
not let them become confluent; they ptdl up more easily than Sf9 and Sf21 when 
they become crowded. 
The Sf2l cells from BRL are adapted to serum free medium and may be 
advantageous to use for protein production, purification, and visualizing secreted 
recombinant proteins on gels. 
Media 
IX GYL (includes fetal calf serum) and IX GYL serum-free 
Sf900IISFM 
Supplier: 
company cat. # volume 
Grace's medium BRL 11300-027 
Yeastolate (SOX) BRL 18190-017 
Lactalbumin hydrolysate (SOX) BRL 18080-010 
Penn-Strep, 10,000 U/ml 
Fetal Calf Serum, heat inactivated at 56°C for 1 hovir 
SfSOOIISFM liquid BRL 10902-013 
powder BRL 20902-045 
10 X IL 
100 ml 
100 ml 
500 ml 
lOxlL 
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IX GYL ~ Grace's medium, yeastolate, lactalbimiin hydrolysate 
Note: Medium is stored at 4°C, but warmed to room temperature before use. 
IX GYL 2XGYL IX GYL serum free 
100 ml 50 ml 100 ml 
50X yeastolate 2ml 2 ml 2ml 
50X lactalbumin hydrolysate 2ml 2ml 2 ml 
fetal calf serum, 5% 5ml 5 ml 0ml 
penn/strep, 10,000 U/ml 100 100 ^il 100 ^il 
Grace's mediimi, IX to volume 0 ml to volume 
Grace's medium, 2X 0ml to volume 0 ml 
freezii^  medium 25 ml 
fetal calf serum (heat inactivated) 5 ml 
penn/strep 25 |il 
DMSO 2.5 ml 
yeastolate (SOX) 0.5 ml 
lactalbumin hydrolysate (50X) 0.5 ml 
Grace's medium, IX salts to volume 
Begin a culture of cells 
1. Bring refiigerated media to room temperature before use. Place 6 ml of the 
appropriate medium (IX GYL or Sf 900II sftn) in a 25 cm^ flask. 
2. Thaw a frozen vial of cells rapidly in a 37°C water bath. 
3. Transfer the vial's contents to the 25 cm^ flask. Rock the flask gently by hand 
to distribute the cells evenly and incubate at 27°C. 
4. Subculture cells the next day, 
Maintaia and subculture the monolayer cultures 
5. Monolayers can be maintained in 25 cm^ flasks with 3 ml medium or 75 cm^ 
flasks with 10 ml of medium. 
6. Subculture by adding 3 ml of medium to a 25 cm^ flask. Add 0.3 to 0.5 ml of 
cells harvested from a nearly confluent 25 cm^ flask. Cells are harvested by 
rapping the flask against the hood to loosen the cells and then rinsing them down 
with a pipet. 
7. Cells shovdd be subcultured every 4-5 days. Do not let them become confluent 
or they will begin to pull up. 
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Suspension cultures 
1. Seed an erlenmeyer flask with 0.5-1.0 x 10® cells/ml and place on a shaker 
shaking at 100 rpm. 
2. Spin cells down every three days and add fresh medixim. Cells should be diluted 
to 0.5-1.0 X 10® cells/ml. 
3. Count the cells with a hemacytometer or coulter counter and subculture cells 
when they reach a density of 2.0-2.5 x 10®. Cells growing in GYL will not likely 
exceed this density but cells growing in commercial serum free medium can 
achieve higher densities. We have achieved densities as high as 5.0 x 10®. 
Freezing cells 
Scrape a nearly confluent 25cm2 flask, spin down cells, and resuspend in 1 ml 
freezing medium. Put cells in a cryovial, wrap cryovials in cotton, place in carton 
and store at -70°C until they can be frozen in liquid nitrogen. 
Preparation of DNA for transfection 
This method is adapted from: K. M. Trotter and H. A. Wood, Transfection 
techniques for producing recombinant baculoviruses in Methods in Molecular 
Biology - Baculovirus expression protocols. C. D. Richardson, ed. 
This procedure is to remove viral DNA from non-occluded virions in the cell culture 
supernatant. 
1. Centrifuge the supernatant at 1000 x g to pellet cells and cell debris. 
2. Pellet the virions at 54,000 x g (20,000 rpm in a Beckman SW 28 rotor) for 1 
hovir at 18°C. Resuspend the virus pellet in a small volixme of 10 mM Tris/0.1 mM 
EDTA, pH 7.5. 
3. Add proteinase K (20 mg/ml stock) and SDS (10% stock) to a final 
concentration of 2 mg/ml and 0.1% respectively. Incubate the mixture at 55°C for 
1 to 16 hours (8 hours is svifficient). 
4. Extract the DNA twice with an equal volvmie phenol/chloroform (1:1). The 
phases should be thoroughly mixed by gently inverting the tube. Vortexing shoiold 
be avoided because of shear forces. Separate the phases by centrifuging at 
12,000 X g for 5 minutes. Gently pipet the aqueous phase to a fresh tube. Use a 
pipet tip with the end cut ofif so that the bore is wide, otherwise the DNA may be 
sheared. 
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5. Extract aqueous phase once with chloroform/isoamyl alcohol (24:1). 
6. Dialyze the aqueous phase containing DNA against 1000 volumes of 10 mM 
Tris/1 mM EDTA, pH 8.0 for 18-24 hours with 3 changes of biaffer. Note it is not 
recommended to precipitate the viral DNA because tMs can lead to damage (This 
may not be true, but several protocols recommend not precipitating viral DNA 
because nicked DNA does not transfect well). The DNA may be used for 
transfection. 
This procedure is to isolate viral DNA from virions occluded in polyhedra. This is 
not recommended with tissue culture derived polyhedra because of the costs of 
obtaining sufficient numbers. Rather, use polyhedra derived from infected insects. 
1. Pellet 10® to 10^ polyhedra at 10,000 x g for 10 min. 
2. Resuspend the polyhedra in 5-10 ml of 50 mM Na2C03 and incubate for 15 
minutes (until clearing occurs) at room temperature. 
3. Centrifuge the mixture at 10,000 x g for 10 minutes to remove tmdissolved 
polyhedra and contaminants. 
4. Pellet the released virions and extract the viral DNA as in step 2 above in 
protocol for removal of viral DNA from non-occluded virions. 
This viral DNA may need to be pxarified further by ultracentrifiigation. 
Transfection procedure for baculovirus 
Adapted from Trotter and Wood, Methods in Molecular Biology-Baculovirus 
Expression Protocols, The Humana Press, Inc. 
There are several procediares for transfecting insect cells. One method is 
calcium phosphate. Initial attempts with this method did not work. This 
method can be successful, but specific conditions need to be determined 
first. Electroporation is another method. Transfection with Hpofectin was 
successfiil on the first attempt. 
Lipofectin~BRL cat no. 18292-011 
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1. Seed a 3 cm dish with 1.2x10® cells in 2.5 ml serum free GYL. Allow 
cells to attach for one hour or, alternatively, seed 0.6 x 10® cells in 2.5 ml 
complete GYL or SF 900II and allow to attach overnight. 
2. Mix the viral DNA and transfer vector DNA in the following 
concentrations: 
1 |ig viral DNA and 2 ng transfer vector 
2 ^ig viral DNA and 5 \ig transfer vector 
Bring the volume to 50|il with serum free GYL in a polystyrene tube. Dilute 
15|il Lipofectin with 50|il serum free GYL, add the diluted DNA mixtiu-e and 
mix gently. Let the mixture stand at room temperature for 15 minutes, 
then add 1.5 ml serum free medium. 
3. Rinse the cells twice with serum free GYL, then add the 1.5 ml 
DNA/Lipofectin mixture. 
4. Incubate cells with the DNA mix for 12 h (can be 3-18h), then 
remove medium and replace with 3 ml complete medirun. At 18 h there 
shoiild be tiny granule-like spots on and aroimd the cells, giving a peppered 
appearance to the culture when examined with inverted light microscope. 
5. At two days post-transfection (that is, 2 days after the addition of 
complete medium) remove mediimi for plaquing. Replace with 3 ml 
complete mediima with 150 |ig/ml X-gal. At four days post-transfection 
remove medium for plaquing and discard cells. If recombinant virus is 
present, a blue color will be visible in the medimn. 
6. Prepare two day post-transfection medium for plaqiaing by making 
dilutions of 10"1,10"2,10'^, and 10"4, Proceed with plaquing procediure. 
The four day post-transfection mediiun may also be used as a transfection 
backup. A disadvantage of four day post-transfection medium is that it 
may be enriched for wild type virus because the wild type virus seems to 
replicate faster than the recombinant virus. 
Plaquing to purify recombinant virus (adiapted from Current 
Protocols) 
1. Using a sterile Pasteur pipet or pipet tip, pick a blue plaque (plaqued 
according to,"plaquing to titer virus stocks" protocol using medium from 2 
day post-transfection cells) and pipet agarose plug into a 1.5 ml eppendorf 
with 1 ml serum free GYL. Vortex to release virus into medium. Prepare 
serial dilutions at 10" 1,10"2, and 10"3 as described in "plaqtiing to titer 
virus stocks" protocol and plaque according to the same protocol. 
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2. Pick more blue plaques for another roimd of plaquing. Repeat plaquing 
until a pure recombinant virus is obtained i.e. no more wild type occlusion 
bodies care visible. Occlusion bodies are very refractile, circular, and have a 
yellowish color. They are very easy to see with a microscope. Pvirifying 
recombinant virus iisually takes three rounds of plaquing. 
3. Pick a pure recombinant plaque, place in 1 ml servim free GYL and 
vortex. Prepare a 6 cm dish of 0.5 x 10® insect cells, add 100 |il of the pure 
recombinant virus stock and incubate 3 to 4 days until most of the cells are 
infected. Harvest the medium from the cells and spin out any cell debris. 
This will be yotir seed stock. Use this to infect cells for a Southern blot and 
to make a large virus stock. Permanently store some of your seed stock by 
freezing at -70C. 
Preparing large-scale viral stock (adapted from Current Protocols) 
1. Grow 50 ml cells in shaking culture to 2 x 10® cells/ml. Centrifuge cells at 1000 
X g and discard supernatant. Resuspend cell pellet in 10 to 20 ml of serum free 
medium containing virus at a MOI of 0.1. Place on shaker for Ih. (can change 
volumes proportionally) 
volume viral stock needed for infection = MOIx # cells to be infected 
titer of viral stock 
titer of viral stock = # plaques/dilution 
2. Bring the voliune to 100 ml with complete medium and place back on shaker. 
Incubate 3 to 5 days. Harvest by centrifoging and removing the medivma which 
contains the virus. 
Plaquing to titer virus stocks (adapted from Current Protocols) 
1. Use exponentially growing insect cells. Seed cells at 1.5-2.0 x 10® cells per 6cm 
tissue culture dish. Make duplicate plates for each viral stock dilution. Let cells 
attach for Ih. 
2. When making dilutions add 100 pi of viral stock to 900 |j1 serum free meditim in 
a 1.5 ml eppendorf and mix. This is a 10"! dilution. Take 100 nl of the 10*1 dilution 
and add to 900 |xl of serum free medium for a 10"2 dilution, etc. To titer 
transfection supernatant make 10"! to lO"^ dilutions for plaquing. To titer large 
viral stocks make 10*5 to 10"^ dilutions for plaquing. 
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3. Aspirate medium from cells and add 1 ml of a viral dilution. Incubate rocking for 
Ih. 
4. While cells are rocking prepare agarose overlay. Add X-gal at a final 
concentration of 150 |ig/ml (X-gal made in DMSO) to 2x GISj (or other 2x medium) 
and place in 40C water bath. Melt agarose (3% low melt agarose in deionized 
water) and place in water bath also. (Seaplaque from FMC or Fisher Biotech cat# 
BP165-25 from chemstores) 
5. After 1 h remove viral supernatant from cells and add 4 ml agarose overlay per 
6 cm dish. Overlay is made by mixing 2ml warm 2x medium containing X-gal with 
2 ml warm agarose and pipetting over cells. Don't do more than 10 plates at a 
time to prevent the possibility of the agarose solidifying while your working. Wrap 
the plates with parafilm and allow to incubate. Plaques usually appear within 4 to 
7 days. Count the plaques to determine titer (# plaques/dilution = titer) 
Extraction of DNA from Virus Infected Cells 
Taken from The Baculovirus Expression System: A Laboratory Guide. L. 
A. Kong and R. D. Possee, ppl42-146. 
This procedure can be used to check if a virus is recombinant during the 
early stages of plaque purification or later to determine if the final stock of 
recombinant virus is correct. If checking for recombination ia the early 
stages of plaque purification, take one of the plaques after the first or 
second round of purification that you are not using for further purification 
and use that one to test for recombination. 
1. Seed a 60 mm dish with 1.0 x 10® cells in complete medium. Allow cells 
to attach for 1 hour. 
2. Remove media and add plaque ( should be 1 ml approximately). 
Alternatively, if the virus is a high titer virus, add at an MOI of 5-10. Rock 
the cells for one hour. In addition, as controls, infect a dish of cells with wild 
type virus and have a no infection control. 
3. Remove the inociilum and discard. Overlay the cells with 2 -3 ml of 
complete medium. Incubate at 28 C. If the amoimt of virus that was 
added was low, wait 3-5 days before harvesting the cells. K infecting at a 
high MOI, harvest the cells after 18 hours. 
4. Remove the cells with a Pasteur pipette and place in a 1.5 ml microfuge 
tube. 
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5. Pellet cells using low-speed centrifligation and discard the supernatant. 
Wash pellet once with 0.5 ml PBS. 
6. Resuspend the cells in 250 jjl TE. Add 250 |xl cell lysis buffer and gently 
mix the contents of the tube. The lysate should become sticky and viscous 
as the cells release DNA. 
7. Add 12.5 pi proteinase K and 2.5 p.1 RNAse A and incubate at 37 C for 30 
min. 
8. Extract the lysate with an equal volimie phenol/chloroform for 5 min. 
Ensure that the organic and aqueous phases are thoroughly mixed, but 
avoid vortexing as this may shear the DNA. Separate the phases by 
spiiming for 5 min. 
9. Remove the aqueous phase and place in fresh tube. Use aJ.jnal pipette 
tip vdth the end cut off. The interface is very viscous and sometime difficult 
to avoid removing. 
10. Repeat steps 8 and 9. 
11. Add 50 (il 3M sodium acetate (miniprep solution #3) and 2 volumes 
ethanol to aqueous phase. A precipitate should be obvious immediately 
after inverting tube to mix. 
12. Pellet DNA for 5 min., wash pellet with 80% ethanol, dry in a speed vac. 
13. Resuspend DNA in 100 |il TE. Either, resuspend very gently or leave in 
4 C overnight and then resuspend. 
14. DNA is now ready to digest for analytical digest and Southern. On a 
gel, there may be some background genomic DNA as contamination, but 
the bands of the baculovirus genome should be obvious. 
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Recombinant protein production time course (adapted from 
Current Protocols) 
1. Seed 2.5-3.0 x 10® cells into the desired number of 6 cm dishes with 5 ml 
complete medium and allow to attach for 1 h. Infect 2 dishes with wildtype 
virus, leave one dish uninfected, and infect the rest with recombinant virus. 
Infect cells at an MOI of 10, The number of dishes infected with 
recombinant virus depends upon the number of times you wish to check for 
protein production post-infection. Harvest cells at various times from 
approximately 15 to 72 h post-infection (eg. recombinant at 15 h, 36h, 48h, 
60h, 72h, and 96h, wild type at 15h and 36h, tminfected at 15h). 
Maximum polyhedrin expression occurs at 36 to 48 h post-infection, 
2. Harvest cells by scraping dishes with a rubber policeman and pipetting 
into an eppendorf Spin at 1000 x g. Discard supernatant and rinse cells 
with PBS by centrifuging again. Discard PBS. Freeze cells at -20 until 
ready to \ase or lyse immediately for SDS-PAGE analysis. Further 
analysis can also be done with immimoblot analysis. 
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